Inflammatory disease
MONDO:0021166A disease involving a pathogenic inflammatory response in the anatomical structure.
Also known as: anatomical structure inflammation, inflammation of anatomical structure, inflammatory disease, inflammatory disorder
9170 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1467 trials in this tab.
-
New vaccine aims to stop deadly diarrhea in kids
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (IP-QSV) designed to protect against four types of Shigella bacteria, which cause severe diarrhea. The trial will include 370 healthy adults, children, and infants in Mali. Researchers will check if the vaccine is safe and triggers a strong immune r…
Phase: PHASE1, PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
Experimental drug aims to reverse liver damage in rare triple condition
Disease control Not yet recruitingThis study tests a drug called foscenvivint in people with liver cirrhosis caused by HIV and hepatitis C co-infection who also have hemophilia. Participants receive the drug once a week for 24 weeks. Researchers will check if the drug improves liver function and is safe to use.
Phase: PHASE2 • Sponsor: Kiminori Kimura, MD • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Not yet recruitingThis study tests whether a cream containing ruxolitinib (Opzelura) combined with corticosteroid injections or pills can improve facial vitiligo. It includes people aged 12 and older with active, non-segmental vitiligo affecting the face. Participants use the cream twice daily and…
Sponsor: ShanShan Li • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple phosphate IV ease severe pancreatitis?
Disease control Not yet recruitingThis study investigates whether giving phosphate through an IV can reduce the severity of acute pancreatitis in adults. Researchers want to know if low phosphate levels make the disease worse and if replenishing it helps. Participants receive either standard care or IV phosphate …
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug shows promise for lung scarring in Long-Term safety trial
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called admilparant in people with pulmonary fibrosis (lung scarring). About 2,277 adults who finished earlier studies will take the drug and be monitored for side effects. The goal is to see if the drug is safe to use over time, …
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a tailored diet make a MASH drug work better?
Disease control Not yet recruitingThis study tests whether adding a Mediterranean-style meal delivery program to resmetirom therapy improves liver health more than resmetirom alone. It involves 120 adults with non-cirrhotic MASH who are starting resmetirom. Participants either receive the drug plus 10 medically t…
Phase: PHASE4 • Sponsor: City University of New York • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Faster, better baby tooth root canals? trial pits two rotary file systems Head-to-Head
Disease control Not yet recruitingThis trial compares two types of rotary files designed for children's primary molars: Fanta AF Baby and EndoArt Pedo Blue. The goal is to see which system prepares root canals faster and with better filling quality during a pulpectomy (removing infected pulp). Thirty children age…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to slow kidney damage in rare alport syndrome
Disease control Not yet recruitingThis study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic errors. The drug is given as a daily shot for 32 weeks. Half the group starts exaluren right away, while the other half gets a placebo first and then switches to…
Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control Not yet recruitingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can reduce inflammation and improve heart function better than the standard filter in people with end-stage kidney disease. Thirty adults on maintenance hemodialysis will use each filter for three …
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Inhaled drug could offer new hope for lung scarring disease
Disease control Not yet recruitingThis phase 2 trial tests whether an inhaled form of nintedanib (MNKD-201) is safe and effective for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring. About 210 adults with IPF will receive either a low or high dose of the inhaled drug or a plac…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple knee sleeve slow arthritis and ease pain?
Disease control Not yet recruitingThis study tests whether wearing a knee sleeve daily for five years can slow the progression of knee arthritis and reduce pain in adults aged 50 to 64 who have had knee pain for at least three months. Participants are randomly assigned to either wear a knee sleeve every day or no…
Phase: NA • Sponsor: Margaret L Gourlay, MD, MPH • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple attack on lung scarring: could plasma exchange and immune therapy slow IPF?
Disease control Not yet recruitingThis Phase II trial tests whether a combination of therapeutic plasma exchange (filtering the blood), rituximab (a drug that targets certain immune cells), and intravenous immunoglobulin (IVIg) can slow lung decline in people with progressive idiopathic pulmonary fibrosis (IPF). …
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Family-Wide dental treatment may break the cycle of oral infections
Disease control Not yet recruitingThis study investigates how bacteria that cause tooth decay and gum disease spread among family members. Researchers will treat either the child alone, the child and parents, or all family members with professional dental cleaning. They will track bacterial transmission using DNA…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common acne drug help beat tough fungal infections?
Disease control Not yet recruitingThis study compares the standard antifungal drug itraconazole alone versus itraconazole combined with isotretinoin (an acne medication) in adults with tinea corporis or cruris (ringworm of the body or groin). The goal is to see if the combination shortens treatment time and impro…
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nasal spray ingredient may offer safer dental pulp treatment for kids
Disease control Not yet recruitingThis study tests whether oxymetazoline, a common nasal decongestant, can replace sodium hypochlorite as a bleeding control agent during pulp treatment in children's baby teeth. About 50 Egyptian children aged 4-8 with decayed molars will receive either treatment. The goal is to s…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug iptacopan studied for rare kidney disease C3G
Disease control Not yet recruitingThis study looks back at the experiences of 35 adults with a rare kidney disease called C3G who received the drug iptacopan through a special early access program in Spain. Researchers will collect information on patient health, lab results, and how the disease responds to treatm…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to tame lupus kidney disease in kids
Disease control Not yet recruitingThis study tests whether combining rituximab with a low dose of mycophenolate mofetil can safely and effectively treat lupus nephritis in children. Lupus nephritis is a serious kidney complication of lupus. The trial enrolls children aged 3 to 18 with active kidney inflammation. …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
HIV drug repurposed to fight muscle inflammation
Disease control Not yet recruitingThis study tests whether Maraviroc, a drug currently used for HIV, can reduce muscle inflammation and improve function in adults with myositis that hasn't responded to standard treatments. Ten participants will take a daily 300mg tablet for 12 weeks and undergo muscle biopsies an…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple ice water flush prevent pancreatitis after a common procedure?
Disease control Not yet recruitingThis trial investigates whether flushing the bile duct opening with ice-cold water after an ERCP procedure can reduce the chance of developing pancreatitis, a frequent complication. Researchers will compare patients who receive the flush to those who do not, looking at pancreatit…
Phase: NA • Sponsor: Oman Ministry of Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood autoimmune diseases
Disease control Not yet recruitingThis early-phase trial tests a single infusion of universal CAR-T cells (RD06-05) in 30 children and adolescents with severe autoimmune diseases, including lupus, scleroderma, and kidney inflammation. The cells are designed to target and calm overactive immune cells. The main goa…
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-stage trial tests an injection called TVAX-028 in adults with chronic hepatitis B. The study checks if the drug is safe and how the body processes it. Participants receive either TVAX-028 with an adjuvant or the adjuvant alone, at different dose levels. The goal is to …
Phase: PHASE1 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a drug calm the immune storm in severe abdominal infections?
Disease control Not yet recruitingThis study tests whether ulinastatin, a drug that reduces inflammation, can help patients with severe abdominal infections. The infection often causes the immune system to overreact, leading to organ failure and high risk of death. Researchers will give patients either a low or h…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Gel boosts gum disease treatment? small study investigates
Disease control Not yet recruitingThis study looks at whether a special gel, called Sterify Gel, can improve the results of standard non-surgical gum disease treatment. Researchers will review records from 20 adults with moderate to severe periodontitis who received deep cleaning plus the gel. The main goal is to…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Head-to-Head: which acne cream works better for clear skin?
Disease control Not yet recruitingThis study compares two topical medications—clascoterone cream and adapalene gel—for treating mild acne vulgaris. Researchers will enroll 60 people aged 12 to 35 with mild acne and randomly assign them to use one of the treatments for 12 weeks. The goal is to see which treatment …
Phase: EARLY_PHASE1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Tailored breathing support may reduce lung injury in ECMO patients
Disease control Not yet recruitingThis study tests whether personalized ventilator settings can reduce lung injury in adults with severe respiratory failure who are on ECMO (a heart-lung machine). Researchers will use esophageal manometry or electrical impedance tomography to tailor the ventilator's positive pres…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a daily probiotic boost gum health in smokers?
Disease control Not yet recruitingThis study tests whether adding a daily synbiotic supplement (probiotics plus prebiotic) to standard non-surgical gum treatment improves gum health in smokers with advanced periodontitis. 92 smokers and non-smokers will be split into four groups, receiving either the supplement o…
Phase: NA • Sponsor: Biruni University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New eye drops aim to calm Sjögren's dry eye by blocking inflammation
Disease control Not yet recruitingThis phase 2 trial tests whether eye drops containing infliximab, a drug that blocks a key inflammatory protein, can safely improve severe dry eye in people with Sjögren's syndrome. 38 adults will receive either the active drops or a steroid drop for 6 weeks. The study measures s…
Phase: PHASE2 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug trial aims to protect Kids' kidneys from IgA nephropathy
Disease control Not yet recruitingThis phase 3 trial tests the drug atrasentan in 28 children aged 2 to 18 with IgA nephropathy, a kidney disease that can lead to kidney failure. The study measures whether atrasentan reduces protein in the urine, a sign of kidney damage, over 36 weeks. All participants receive th…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Poop pills for painful skin? fecal transplant trial targets hidradenitis
Disease control Not yet recruitingThis pilot study tests whether fecal microbiota transplantation (FMT) can improve moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will give 24 adults a single FMT and track changes in their skin lesions over 12 weeks. The goal is to see if …
Phase: PHASE1 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental CAR-T therapy takes on tough lupus cases
Disease control Not yet recruitingThis early-stage trial tests a new treatment called P-CD19CD20-ALLO1, a type of CAR-T cell therapy, for people with severe lupus that hasn't improved with standard treatments. The study will enroll 162 participants and aims to check if the therapy is safe and tolerable. It also l…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Ancient herbs meet modern medicine: can Curcumin-QingDai tame UC?
Disease control Not yet recruitingThis study tests whether adding a combination of curcumin (from turmeric) and QingDai (a traditional Chinese herb) to standard vedolizumab treatment can help people with moderate to severe ulcerative colitis reach remission. About 160 adults will receive either the herbal combo o…
Phase: PHASE4 • Sponsor: Ryan C Ungaro • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill shows promise for controlling painful skin condition in long-term trial
Disease control Not yet recruitingThis phase 3 study tests the long-term safety and effectiveness of remibrutinib, an oral drug, in 710 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants have already completed a prior remibrutinib study. …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a tiny eye implant tame chronic uveitis Flare-Ups?
Disease control Not yet recruitingThis study will follow 100 adults with non-infectious posterior uveitis, a chronic inflammatory eye disease, who have received a fluocinolone acetonide implant. Researchers will analyze medical records over three years to see how well the implant reduces the frequency and severit…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Community health workers may boost antibiotic adherence for rheumatic heart disease
Disease control Not yet recruitingThis study tests whether community health workers (CHWs) can help people with rheumatic heart disease (RHD) take their monthly antibiotic shots consistently. The trial will enroll about 308 participants in Brazil and Timor-Leste, including adults and children with RHD and their c…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New skin cell transplant combo aims to restore color in white patches
Disease control Not yet recruitingThis study tests two surgical techniques to treat stable white patches on the skin that are not caused by vitiligo. Both methods involve transplanting the patient's own skin cells, followed by laser therapy to boost color return. Twenty-two adults will each receive both treatment…
Phase: NA • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a simpler eczema routine boost treatment success?
Disease control Not yet recruitingThis study explores whether giving people with mild-to-moderate eczema a straightforward treatment plan using only Opzelura cream helps them stick to their medication routine. Participants apply the cream twice daily until their skin clears, then as needed. Some participants also…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Which steroid works best for thick, itchy skin plaques?
Disease control Not yet recruitingThis study compares two standard steroid treatments for hypertrophic lichen planus, a chronic skin condition that causes thick, intensely itchy plaques. Fifty adults will be randomly assigned to apply a strong steroid cream twice daily for 12 weeks or receive steroid injections i…
Phase: PHASE4 • Sponsor: Noor Aziz • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to tame liver side effects of cancer immunotherapy
Disease control Not yet recruitingThis study tests whether combining mycophenolate mofetil (MMF) with prednisone can better treat liver inflammation caused by checkpoint inhibitor cancer drugs. The trial includes adults with moderate to severe immune-related hepatitis who need to pause their cancer therapy. The m…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a gentler mouthwash win kids over without sacrificing gum health?
Disease control Not yet recruitingThis study tests whether a hyaluronic acid mouthwash is more acceptable to children than a standard chlorhexidine mouthwash, while still controlling plaque-induced gingivitis. Thirty-two children aged 8 to 12 with signs of gingivitis will use one of the two mouthwashes. Researche…
Phase: PHASE1 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New foot fungus film shows promise in early trial
Disease control Not yet recruitingThis early-stage trial tests a new topical film called ZYG24004 for athlete's foot (tinea pedis). About 64 adults with the infection will apply the film to their feet once or twice. The main goals are to check safety, how the body processes the drug, and whether it can clear the …
Phase: PHASE1 • Sponsor: Sinomune Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for uveitis: Anti-Inflammatory drug tested in chinese patients
Disease control Not yet recruitingThis study tests the drug adalimumab (Tebiovio®) in 30 adults with non-infectious uveitis, an inflammatory eye disease. The goal is to see if the drug can control inflammation and prevent treatment failure. Participants will receive injections and be monitored for up to 24 weeks.…
Phase: PHASE4 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
Disease control Not yet recruitingThis study tests whether a 5-day course of inhaled amikacin can prevent ventilator-associated pneumonia in critically ill patients who already have a milder airway infection called tracheobronchitis. 250 adults on breathing machines will receive either the drug or a placebo. The …
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThis phase 2a trial tests whether a daily pill called ACT-777991 can help return color to the face of adults with non-segmental vitiligo. About 30 participants will take either the drug or a placebo for 24 weeks. Researchers will measure changes in skin color using a standard sco…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can stem cell exosomes heal Radiation-Damaged bladders?
Disease control Not yet recruitingThis early-phase trial tests whether a combination of stem cell exosomes and sodium hyaluronate, instilled directly into the bladder, can safely treat radiation cystitis—a painful condition causing bleeding and urinary problems after pelvic radiotherapy. 48 women aged 18-80 will …
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for brain infection: experimental combo tackles tuberculous meningitis
Disease control Not yet recruitingThis study tests a new combination of medicines (BPaLMZ) against the standard treatment for tuberculous meningitis, a serious brain infection. About 240 adults, including those living with HIV, will take part. The goal is to see if the new combo helps more people survive and reco…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a diabetes drug tame the immune system in kidney disease?
Disease control Not yet recruitingThis phase 2 trial tests whether dapagliflozin, a drug used for diabetes and heart failure, can reduce harmful antibodies and prevent relapses in people with membranous nephropathy, an autoimmune kidney disease. The study enrolls 20 adults who have had a recent rise in anti-PLA2R…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug shows promise for severe eczema in toddlers
Disease control Not yet recruitingThis study tests a drug called nemolizumab in toddlers aged 6 to 23 months with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams or ointments. The goal is to see how the drug moves through the body, if it is safe, and if it helps control the conditio…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can berries and olives tame inflammation? new study seeks answers
Disease control Not yet recruitingThis pilot study will test whether supplements made from bilberries and olives can reduce inflammation and oxidative stress in people with prediabetes who are overweight. Researchers will collect blood, urine, and stool samples from 60 participants to measure changes in key healt…
Phase: NA • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New injections aim to melt liver fat in MASH patients
Disease control Not yet recruitingThis clinical trial tests two experimental injections, HRS-4729 and HRS9531, in adults with metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition linked to obesity. The study involves 160 participants who receive either the drug or a placebo for 52 we…
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New trial combines HIV PrEP and STI prevention in one package for young men
Disease control Not yet recruitingThis study tests whether a combined approach—offering HIV PrEP (pills or injections) and STI prevention (doxycycline after sex) along with smartphone tools—helps young men at high risk stay protected. About 400 men aged 18-29 who have sex with men will be followed for a year to s…
Phase: PHASE3 • Sponsor: HIV Prevention Trials Network • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take aim at Hard-to-Treat lupus
Disease control Not yet recruitingThis trial tests a one-time treatment called CAR-T cell therapy for people with systemic lupus erythematosus (lupus) that hasn't improved with standard medications. The therapy uses a patient's own immune cells, which are modified in a lab to find and destroy the B cells that dri…
Phase: PHASE1, PHASE2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can hip exercises protect knee cartilage in osteoarthritis?
Disease control Not yet recruitingThis trial investigates whether adding hip strengthening exercises to a standard quadriceps program better preserves knee cartilage thickness and improves symptoms in people with knee osteoarthritis. Fifty-six adults with mild-to-moderate knee OA will be randomly assigned to one …
Phase: NA • Sponsor: Pamukkale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drainage procedure could prevent gallbladder attacks without surgery
Disease control Not yet recruitingThis trial tests whether a procedure called EUS-guided gallbladder drainage can prevent future gallbladder attacks in people who are too sick or frail for surgery. Participants are randomly assigned to receive either the drainage procedure or standard medical care. The study will…
Phase: NA • Sponsor: Hospital Mutua de Terrassa • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New shot aims to tame hepatitis b without daily pills
Disease control Not yet recruitingThis phase 2 trial tests an experimental drug called AHB-137 in 70 adults with chronic hepatitis B who are already on antiviral pills. The drug is given as a shot under the skin. The goal is to see if it can lower the virus to undetectable levels and allow some people to stop the…
Phase: PHASE2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Takhzyro under the microscope: Real-World safety check for rare swelling disease
Disease control Not yet recruitingThis study looks at how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) in everyday medical care in South Korea. HAE is a rare condition that causes sudden swelling under the skin or inside the body. The study will track side effects and h…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug takes aim at deadly lung complication
Disease control Not yet recruitingThis small study will test a drug called emapalumab in 5 adults with a rare, rapidly worsening lung disease linked to dermatomyositis. The drug is already used for a similar immune overreaction condition. Researchers will check if it improves oxygen needs, lung function, and CT s…
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Knee fluid drain or blood injection may curb arthritis after ACL tear
Disease control Not yet recruitingThis study tests two procedures done before ACL surgery: draining excess knee joint fluid (arthrocentesis) or injecting platelet-rich plasma (PRP) from the patient's own blood. The goal is to see if either reduces inflammatory chemicals linked to cartilage damage. About 99 adults…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug hope for GPA patients with stubborn ENT symptoms
Disease control Not yet recruitingThis study tests whether adding TAVNEOS to standard treatment helps control ear, nose, and throat symptoms in people with granulomatosis with polyangiitis (GPA). About 30 adults with active ENT disease will receive either TAVNEOS or a placebo for 52 weeks. The goal is to see if m…
Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill could stop liver scarring in MASH patients
Disease control Not yet recruitingThis Phase 3 trial tests whether the drug HSK31679 can safely improve liver health in 400 adults with MASH, a serious fatty liver disease. Participants will take either the drug or a placebo daily for about a year. The main goals are to see if the drug can reverse liver inflammat…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common liver drug replace steroids for immunotherapy side effects?
Disease control Not yet recruitingThis phase 2 trial tests whether ursodeoxycholic acid (UDCA), a drug already used for other liver conditions, can treat cholestatic hepatitis—a liver inflammation caused by immunotherapy—better than standard steroids. About 94 adults with cancer (excluding liver cancer) who devel…
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Dentist's deep clean may delay dialysis for kidney patients
Disease control Not yet recruitingThis study tests whether a deep dental cleaning (subgingival instrumentation) can slow the progression of chronic kidney disease in 40 adults with diabetes and stage IV-V kidney disease. The cleaning aims to reduce inflammation that may worsen kidney function. Researchers will me…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immune cell therapy aims to stop BK virus bladder bleeding in transplant patients
Disease control Not yet recruitingThis early-phase trial tests a new treatment called LB-DTK-BKV for people who develop painful bladder bleeding (hemorrhagic cystitis) from BK virus after a stem cell transplant. The treatment uses immune cells from a donor that are trained to attack the virus. About 42 children a…
Phase: PHASE1, PHASE2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to tame severe gut disease
Disease control Not yet recruitingThis study tests an experimental tablet called Hemay005 in 360 Chinese adults with moderate to severe ulcerative colitis, a chronic gut condition. Participants will receive either the drug or a placebo to see if it can bring about remission and improve symptoms over 12 weeks, wit…
Phase: PHASE3 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a natural supplement calm ulcerative colitis?
Disease control Not yet recruitingThis study tests whether a supplement called palmitoylethanolamide (PEA) can help people with mild-to-moderate ulcerative colitis. Researchers will measure changes in disease activity, quality of life, and inflammation markers in 60 participants. The goal is to see if adding PEA …
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot plus light therapy aims to restore skin color in vitiligo
Disease control Not yet recruitingThis study tests a new medicine called GR2301, given as shots under the skin, together with light therapy for people with vitiligo (a condition that causes white patches on the skin). The trial has two parts: first, finding the right dose, then testing how well it works. About 11…
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests endoscopic gallbladder drainage as surgery alternative
Disease control Not yet recruitingThis study will follow 220 patients with benign gallbladder diseases who cannot have surgery. It compares two non-surgical approaches: endoscopic drainage with possible stone removal versus traditional drainage alone. The goal is to see which method leads to fewer complications a…
Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shorter antibiotic course may be just as effective for kids with pneumonia
Disease control Not yet recruitingThis study tests whether a 3-day course of amoxicillin works as well as a 5-day course for children aged 3 months to 5 years with uncomplicated pneumonia. The goal is to see if shorter treatment can reduce side effects, lower costs, and fight antibiotic resistance. About 250 chil…
Phase: EARLY_PHASE1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Keyhole vs open surgery for tennis elbow: which offers better pain relief?
Disease control Not yet recruitingThis trial compares two surgical approaches for tennis elbow that has not improved after at least six months of non-surgical treatments like rest or physical therapy. One group receives keyhole (arthroscopic) surgery, while the other receives traditional open surgery. The main go…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug HBM7020 tested in humans for first time against autoimmune diseases
Disease control Not yet recruitingThis first-in-human study tests the safety of a new drug called HBM7020. It will first be given to healthy volunteers at low doses, then to people with moderate to severe autoimmune diseases like lupus, rheumatoid arthritis, scleroderma, and Sjögren's disease. The goal is to see …
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Hormone pretreatment may boost IVF success in stubborn uterine infection
Disease control Not yet recruitingThis study looks at whether giving a GnRH agonist hormone treatment before a frozen embryo transfer can improve pregnancy and live birth rates in women with persistent chronic endometritis (a uterine infection that doesn't clear with antibiotics). About 150 women aged 20-40 will …
Sponsor: Guoxia Yang • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New study could change how Men's UTIs are treated
Disease control Not yet recruitingThis study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor f…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Silver dressings could simplify infection care for dialysis patients
Disease control Not yet recruitingThis pilot study tests whether silver-impregnated dressings can effectively manage catheter exit-site or tunnel infections in adults on peritoneal dialysis. Sixty participants will be randomly assigned to receive either the silver dressing or standard daily antibiotic dressings, …
Phase: NA • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Fish oil derivative may calm heart inflammation and stabilize plaques
Disease control Not yet recruitingThis study looks at whether icosapent ethyl, a purified fish oil medication, can reduce inflammation and improve heart structure in people with coronary artery disease. Researchers will follow 420 patients for one year, comparing those who receive standard care plus icosapent eth…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill for chronic hives tested in everyday clinics
Disease control Not yet recruitingThis study follows 470 adults with chronic spontaneous urticaria (hives) who are starting remibrutinib, a new drug. Researchers will track how well it controls symptoms and any side effects over two years in real-world clinics. The goal is to see if remibrutinib works as well out…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug BHV-1400 aims to protect kidneys in IgA nephropathy
Disease control Not yet recruitingThis Phase 3 trial tests whether BHV-1400 can safely reduce protein in the urine and preserve kidney function in 420 adults with IgA nephropathy. Participants are randomly assigned to receive either the drug or a placebo by injection. The main goal is to see if BHV-1400 lowers pr…
Phase: PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a lower dose of acne drug work just as well with fewer side effects?
Disease control Not yet recruitingThis study tests whether a low daily dose of the acne drug isotretinoin can clear moderate to severe acne as effectively as the standard dose, but with fewer side effects. About 164 people aged 18-45 will be randomly assigned to one of two dose groups. Researchers will track acne…
Phase: PHASE4 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common supplement help liver patients in intensive care?
Disease control Not yet recruitingThis study looks at whether adding L-carnitine, a natural substance, to standard care can improve outcomes for critically ill adults with liver disease in the ICU. About 58 participants with conditions like liver failure or severe infections will be enrolled. Researchers will tra…
Phase: PHASE4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New eczema pill shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental pill called ENV-294 for adults with moderate-to-severe atopic dermatitis (eczema). About 200 participants will take either one of three doses of ENV-294 or a placebo daily for 12 weeks. Researchers will measure changes in eczema severity, symptoms…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Poop pills could tame stubborn arthritis
Disease control Not yet recruitingThis study tests whether freeze-dried fecal bacteria, given as oral capsules, can improve symptoms in 40 adults with active rheumatoid arthritis that hasn't responded to standard drugs. Participants will receive either the fecal transplant or a placebo for 24 weeks. The main goal…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New trial aims to find best treatment for lung complication in rheumatoid arthritis
Disease control Not yet recruitingThis 52-week study will compare three drugs—tocilizumab, telitacicept, and methotrexate—in 204 people with rheumatoid arthritis who also have interstitial lung disease. The main goal is to see which drug best improves lung function. Participants will continue their usual arthriti…
Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for teens with rare nerve disease: drug trial launches
Disease control Not yet recruitingThis study tests a new medicine called empasiprubart in teenagers aged 12 to 17 who have a rare nerve disease called CIDP. The goal is to find the right dose and see if the drug is safe and helps control the disease. Participants will receive the drug for about 27 months and be f…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a few weeks of pre-surgery weight training boost hip replacement recovery?
Disease control Not yet recruitingThis study tests whether a supervised resistance exercise program, done for 2 weeks before and 12 weeks after total hip replacement, improves muscle mass and strength in adults aged 60 and older with severe hip osteoarthritis. Participants are randomly assigned to either the exer…
Phase: NA • Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Texting your way to healthier gums: new study tests phone reminders for Hard-to-Clean teeth
Disease control Not yet recruitingThis study looks at whether mobile health reminders can help people with gum disease keep their teeth cleaner after standard treatment. The trial will include 76 adults with gum disease affecting the roots of their back teeth. Participants will receive text or app reminders to im…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Psoriasis patients: does your injection schedule matter?
Disease control Not yet recruitingThis study looks at 120 adults with moderate-to-severe psoriasis who take secukinumab, a biologic drug. It compares two maintenance schedules: the standard every-4-week injection versus a non-standard schedule (longer intervals or lower dose). The goal is to see which schedule ke…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingThis study tests a gel made from doxycycline and atorvastatin in tiny chitosan particles, placed directly into gum pockets after standard deep cleaning. The goal is to reduce gum inflammation, pocket depth, and bone loss in 80 adults with moderate to severe chronic periodontitis.…
Phase: PHASE4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Stem cells take on ankylosing spondylitis: first human trial begins
Disease control Not yet recruitingThis early-phase trial is testing whether stem cells from donated bone marrow (CG-BM1) are safe for people with ankylosing spondylitis, a chronic inflammatory arthritis. Forty adults aged 18 to 40 will receive either the stem cells or a placebo by IV once a week for four weeks. T…
Phase: PHASE1 • Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug aims to melt liver fat and stop scarring in MASH patients
Disease control Not yet recruitingThis study tests an experimental drug called ALN-CIDEB in 150 adults with MASH, a serious liver disease involving fat buildup and scarring. The goal is to see if the drug can reduce liver fat, injury, and scarring compared to a placebo. Participants will receive either the drug o…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New study tests tezepelumab for chronic sinusitis sufferers
Disease control Not yet recruitingThis study follows 200 adults with severe chronic sinusitis and nasal polyps who are starting tezepelumab as part of their routine care. Researchers will track changes in symptoms and quality of life over up to two years using patient questionnaires. The goal is to see how well t…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New psoriasis cream takes on old standby in Head-to-Head trial
Disease control Not yet recruitingThis study will test whether a newer cream called tapinarof works better than the standard betamethasone cream for mild-to-moderate plaque psoriasis. About 120 adults will use one of the two creams daily for up to 12 weeks. The main goal is to see how many people get at least a 7…
Phase: PHASE4 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple gel boost gum healing in diabetes?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep cleaning (scaling and root planing) improves gum healing in people with both diabetes and advanced gum disease. Twenty-three participants will receive the standard cleaning on all teeth, and then two gum pockets…
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New injection aims to suppress hepatitis b virus
Disease control Not yet recruitingThis phase 2 trial tests an injection called AHB-137 in adults with chronic hepatitis B who have not yet received treatment. The study compares AHB-137 to a placebo to see if it can lower the amount of hepatitis B virus in the blood and reduce a key marker of infection (HBsAg). P…
Phase: PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells aim to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early-stage trial tests a one-time infusion of donor immune cells (CAR-γδT cells) designed to target and destroy faulty B cells in people with severe autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose in 9 adults whose di…
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThis study tests an experimental drug called ATH-063 in 120 adults with moderate to severe ulcerative colitis who have not responded to or can no longer use biologic therapies. Participants will receive either the drug or a placebo for 12 weeks to see if it can reduce symptoms an…
Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Head-to-Head: which JAK inhibitor tames rheumatoid arthritis best?
Disease control Not yet recruitingThis study will compare two drugs, tofacitinib and upadacitinib, added to standard methotrexate treatment for rheumatoid arthritis. One hundred adults in Pakistan will take one of the two drugs daily for six months. Researchers will measure disease activity and side effects to se…
Phase: PHASE4 • Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Laser and dye combo may boost gum disease treatment
Disease control Not yet recruitingThis study tests whether adding a light-activated dye (photodynamic therapy) to standard deep cleaning improves gum disease more than cleaning alone. Thirty adults with periodontitis will have one side of their mouth treated with cleaning plus the dye/laser, and the other side wi…
Phase: NA • Sponsor: Universidad Catolica Santiago de Guayaquil • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Stem cell nasal spray takes on sinusitis
Disease control Not yet recruitingThis study tests a new nasal spray for adults with chronic sinusitis. The spray turns into a gel inside the nose and releases three active ingredients: stem cell exosomes to help repair the nasal lining, an antihistamine to reduce inflammation, and an antiviral agent. The goal is…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Triple-Action nasal spray could ease chronic sinusitis
Disease control Not yet recruitingThis early-stage trial tests a nasal spray for adults with chronic sinusitis (without polyps). The spray contains stem cell exosomes to heal the nose lining, an antibiotic to kill bacteria, and an enzyme to break up thick mucus. 108 participants will use the spray twice daily for…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Real-World study tracks how long patients stick with gut disease drug
Disease control Not yet recruitingThis study observes 35 adults with moderate-to-severe Crohn's disease or ulcerative colitis to see how long they continue taking guselkumab in everyday medical practice. Researchers will track treatment persistence and early symptom relief, like reduced bowel urgency. No experime…
Sponsor: Janssen-Cilag Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a monthly pill replace painful penicillin shots for rheumatic heart disease?
Disease control Not yet recruitingThis study will test if taking oral azithromycin pills for three days each month works as well as getting a monthly penicillin shot to prevent rheumatic heart disease from getting worse. The trial plans to enroll 474 Nigerian secondary school students aged 10-18 with mild or mode…
Phase: NA • Sponsor: Ladoke Akintola University of Technology, Ogbomoso, Nigeria • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo aims to tame rare inflammatory disease
Disease control Not yet recruitingThis study tests two experimental drugs, goflikicept and olokizumab, in 52 adults with Still's disease, a rare inflammatory condition. The goal is to see if these drugs can quickly bring the disease under control and keep it from flaring up. Participants will receive either the s…
Phase: PHASE3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can an ancient herbal remedy tame rheumatoid arthritis?
Disease control Not yet recruitingThis study tests whether adding a Chinese herbal formula (Si Miao Xiao Bi Tang) to standard rheumatoid arthritis medication can improve symptoms. About 132 adults with active RA will receive either the herbal medicine or a placebo for 12 weeks. The main goal is to see if more peo…
Phase: PHASE2, PHASE3 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a hyaluronic acid gel help Smokers' gums heal better?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep-cleaning treatment improves gum healing in smokers with advanced periodontitis. Twenty-three smokers will receive the standard cleaning, then some gum pockets will also get the gel. Researchers will measure gum …
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cevostamab enters early human testing for lupus
Disease control Not yet recruitingThis early-stage trial will test the safety and tolerability of a new drug, cevostamab, in 46 people with systemic lupus erythematosus, some of whom also have active lupus nephritis. The drug is given intravenously, and researchers will monitor side effects and how the drug moves…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New shot aims to silence hepatitis b virus for good
Disease control Not yet recruitingThis Phase 2 trial tests an injection called AHB-171 in 138 people with chronic hepatitis B. The goal is to see if it can lower hepatitis B surface antigen and viral DNA to very low levels, potentially leading to a functional cure. Participants include those who have never been t…
Phase: PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Ancient toothbrush plant tested as a modern pulp saver
Disease control Not yet recruitingThis study tests whether a paste made from Salvadora persica (a plant used in traditional toothbrushes) mixed with zinc oxide can work as well as the standard material (MTA) for treating severe tooth inflammation. The trial involves 78 adults aged 18-40 with infected permanent mo…
Phase: NA • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Promising drug could save lives in rare, deadly lung disease
Disease control Not yet recruitingThis study tests a drug called teclistamab in 24 adults with a severe, rapidly worsening lung disease linked to anti-MDA5 antibodies. The disease has a very poor outlook, with only about 25% of patients surviving 90 days without a lung transplant. Teclistamab aims to improve surv…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could 3D-Printed teeth and hyaluronic acid tame gum disease?
Disease control Not yet recruitingThis study looks at whether adding hyaluronic acid to temporary dental crowns (made by 3D printing or milling) can improve gum health and surface smoothness. Sixty adults with moderate gum disease will receive one of the two crown types, and their gum attachment, bleeding, and pl…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Ancient gut therapy takes on allergies in new clinical trial
Disease control Not yet recruitingThis study tests whether an Ayurvedic treatment that targets digestion and gut health can reduce allergy symptoms and immune markers in people with allergic rhinitis (hay fever). 104 adults aged 18-40 with confirmed allergies will receive either the Ayurvedic treatment plus stand…
Phase: NA • Sponsor: Amrita Vishwa Vidyapeetham • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New ear tube robot could make surgery quicker and safer for kids
Disease control Not yet recruitingThis study tests a new handheld device called CLiKX that helps doctors place ear tubes in children and adults with chronic ear infections or fluid buildup. The device uses sensors and controlled force to make the procedure more precise. Researchers will check if the tube is place…
Phase: NA • Sponsor: ClinQure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill could help restore skin color in vitiligo patients
Disease control Not yet recruitingThis study tests an experimental drug called D-2570 in 160 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants take either D-2570 or a placebo pill once daily for 24 weeks, with an optional 24-week extension. The goal is to see if t…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Oxygen + light: a new hope for vitiligo repigmentation?
Disease control Not yet recruitingThis study tests whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard narrowband UVB light treatment can help restore skin color in people with vitiligo. Five adults with non-segmental vitiligo will receive UVB twice a week for 24 …
Phase: PHASE2, PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New gastritis pill faces off against standard treatment in 470-Patient trial
Disease control Not yet recruitingThis study tests whether a new tablet called Sto M Tab. works as well as the standard treatment Stillen Tab. for people with acute or chronic gastritis (stomach lining inflammation). About 470 adults aged 19-75 will take one of the two tablets for 2 weeks. The main goal is to see…
Phase: PHASE4 • Sponsor: Mather's Pharm. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingThis study tests a treatment called extracorporeal photopheresis (ECP) for people with advanced melanoma who develop severe colitis or hepatitis from immunotherapy. ECP filters a patient's blood, treats it with a light-activated drug, and returns it to the body. The trial compare…
Phase: PHASE2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Eye drop showdown: which cyclosporine works best for dry eyes?
Disease control Not yet recruitingThis study compares two approved cyclosporine eye drops—Vevye (0.1%) and a generic (0.05%)—in 60 adults with dry eye disease. Over 8 weeks, researchers will measure changes in goblet cells, which produce mucus to keep eyes moist. Participants use drops daily and visit the clinic …
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Simpler h. pylori treatment could reduce antibiotic use
Disease control Not yet recruitingThis study tests whether a simpler two-drug treatment (vonoprazan plus one antibiotic) works as well as a three-drug treatment (vonoprazan plus two antibiotics) for H. pylori infection. About 150 adults with confirmed H. pylori will take either regimen for 14 days. The main goal …
Phase: PHASE4 • Sponsor: Damascus Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New fizzy tablet could keep dentures Germ-Free
Disease control Not yet recruitingThis study tests whether a new experimental effervescent tablet can clean removable partial dentures better than a commercial cleanser or water. Fifteen adults with denture stomatitis will wear dentures with small material discs to collect plaque, then soak them daily in one of t…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hip stem put to the test in 95 patients
Disease control Not yet recruitingThis study will test a new cementless hip stem (Mfinity collared stem) in 95 adults needing total hip replacement due to osteoarthritis. The main goal is to see how many implants survive without needing revision after one year, with a follow-up at two years. Researchers will trac…
Phase: NA • Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New shot aims to reverse liver scarring in MASH patients
Disease control Not yet recruitingThis Phase 2 trial tests a new drug called QL2401 in 132 adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate liver scarring. Participants receive weekly injections of either QL2401 or a placebo for 48 weeks. The main goal is to see if the drug reduces…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-phase study tests a new injectable drug called AHB-171 in 144 adults with chronic hepatitis B. The main goals are to check the drug's safety and how the body processes it. Some participants will also take standard oral antivirals. The study is not yet recruiting.
Phase: PHASE1 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a Nano-Irrigation save dead teeth?
Disease control Not yet recruitingThis study tests whether a special irrigation solution called nanochitosan can help regenerate damaged tissue in infected teeth. Sixty adults with dead teeth and chronic infection will receive one of three irrigation methods during a single dental visit. Researchers will check fo…
Phase: NA • Sponsor: Suez Canal University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Smart cap aims to boost medication adherence in lung disease patients
Disease control Not yet recruitingThis study will test if a smart pill bottle cap, called FORTISKAP™, helps people with serious lung diseases like pulmonary fibrosis, sarcoidosis, and pulmonary hypertension take their oral medications more consistently. About 100 participants will either use the smart cap or rece…
Sponsor: Cosmos Rx, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a saline flush during labor shield newborn brains?
Disease control Not yet recruitingThis study tests whether infusing fluid into the uterus during labor (amnioinfusion) can reduce brain injury in newborns whose mothers have a uterine infection called chorioamnionitis. The infection can cause inflammation and fever that may stress the baby's brain before birth. R…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental CAR-T injection aims to tame autoimmune diseases
Disease control Not yet recruitingThis early-phase trial tests an injection called KSVCBD, a type of CAR-T cell therapy, in 60 adults with severe autoimmune diseases like lupus and scleroderma. The goal is to see if it's safe and to get a first look at whether it might help control the disease. Participants recei…
Phase: EARLY_PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Ancient herbs meet modern viruses in fight against superbug pneumonia
Disease control Not yet recruitingThis early-phase trial will test a combination of a Chinese herbal formula (Yiqi Huoxue Jiedu) and bacteriophages (viruses that target bacteria) in 250 people with severe pneumonia caused by drug-resistant bacteria. The goal is to see if this combo can clear the infection faster …
Phase: EARLY_PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Not yet recruitingThis study tests an experimental drug called STL303 for people with IgA nephropathy, a kidney disease. About 15 adults will receive either STL303 or a placebo to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Possible side effects include na…
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a common gout drug ease thyroid inflammation?
Disease control Not yet recruitingThis study tests whether low-dose colchicine, a drug used for gout, can reduce inflammation and symptoms in people with autoimmune or subacute thyroiditis. About 300 adults will be randomly assigned to colchicine, corticosteroids, or supportive care. The goal is to see if colchic…
Phase: PHASE2, PHASE3 • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Gum disease breakthrough? new hydrogel fights infection and regrows bone
Disease control Not yet recruitingThis study tests a new gel that slowly releases medicine to treat advanced gum disease (periodontitis). The gel is placed directly into deep gum pockets to fight infection, reduce swelling, and help bone grow back. Researchers will study 80 people with severe gum disease to see i…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Gel that regrows bone could save teeth from gum disease
Disease control Not yet recruitingThis study tests an injectable gel containing a bone-growth protein (BMP-2) to help regrow bone damaged by severe gum disease. The gel is designed to fight bacteria, reduce inflammation, and promote bone repair. Researchers will enroll 80 people with advanced periodontitis and bo…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New shot aims to silence hepatitis b virus for good
Disease control Not yet recruitingThis study tests an experimental injection called HRS-5635 in adults with chronic hepatitis B whose virus is already controlled by daily pills. The goal is to see if the injection can help the body clear the virus so patients can safely stop all hepatitis B medications. About 540…
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Knee surgery showdown: which alignment works best for arthritic bow legs?
Disease control Not yet recruitingThis trial compares two ways of aligning the knee during a bone-cutting surgery (high tibial osteotomy) for people with knee arthritis and bow legs. One method aims for natural knee motion (kinematic), the other for straight leg alignment (mechanical). The study will track 100 ad…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can spirulina and fish oil tame immunotherapy lung side effects?
Disease control Not yet recruitingThis study looks at whether adding a mix of nutritional supplements (spirulina, bifidobacterium, fish oil, grape seed, blueberry, and ganoderma spore oil) to standard steroid treatment can help people with severe lung inflammation caused by cancer immunotherapy. About 60 adults w…
Phase: NA • Sponsor: Guangzhou Institute of Respiratory Disease • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
No-Stitch eye glue could spare patients pain and scarring
Disease control Not yet recruitingThis study tests a special hydrogel that acts like a glue to hold eye tissues together during surgery, avoiding the need for stitches. Stitches can cause pain, swelling, and scarring, but this gel uses light to bond quickly and gently. The trial will include 20 people with cornea…
Phase: NA • Sponsor: Suxia Li • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Rosemary vs. root canal: could a kitchen herb save your tooth?
Disease control Not yet recruitingThis study compares rosemary extract to a standard material (MTA) for treating severe tooth pulp inflammation. Researchers will treat 100 adults with a damaged tooth, placing either rosemary extract or MTA directly on the pulp. They will then measure pain and healing over time to…
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug targets immune system to fight Salt-Sensitive hypertension
Disease control Not yet recruitingThis study tests a drug called 2-HOBA in 20 adults with salt-sensitive high blood pressure. The drug aims to calm overactive immune cells that may worsen blood pressure when salt is eaten. Researchers will measure blood pressure changes and blood vessel health after taking 2-HOBA…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Virus cocktail targets superbug pneumonia in first human test
Disease control Not yet recruitingThis early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Blood thinner may stop organ failure in pancreatitis patients
Disease control Not yet recruitingThis study tests whether giving the blood thinner heparin early can prevent organ failure in people hospitalized with acute pancreatitis. The inflammation from pancreatitis can cause tiny blood clots that damage organs like the lungs and kidneys. Half of the 100 participants will…
Phase: PHASE4 • Sponsor: Allied Hospital Faisalabad • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for kidney patients: drug aims to prevent relapse
Disease control Not yet recruitingThis study tests whether a 15-month course of Nefecon can prevent proteinuria relapse in 288 adults with IgA nephropathy who have already achieved remission. Participants must have completed prior Nefecon therapy and have stable kidney function. The goal is to see if maintenance …
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a single injection fix early hip arthritis?
Disease control Not yet recruitingThis study tests an experimental injection called TG-C for people with early hip osteoarthritis. The injection contains cells that release a growth factor to help repair damaged cartilage. 255 adults will receive either TG-C or a placebo, and researchers will track pain and hip f…
Phase: PHASE2 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New shot for hepatitis b heads into early safety testing
Disease control Not yet recruitingThis early-stage study tests a single injection of AHB-137 in 32 people with chronic hepatitis B, some with mild to moderate liver dysfunction and some with normal liver function. Researchers will measure how the drug moves through the body and check for safety issues. The goal i…
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could antibiotics replace surgery for Kids' appendicitis?
Disease control Not yet recruitingThis study tests whether treating children with uncomplicated appendicitis using antibiotics alone works as well as surgery. About 724 children aged 5 to 15 will be randomly assigned to receive either antibiotics or an operation. The goal is to see if the antibiotic approach lead…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New shot could tame severe gum disease
Disease control Not yet recruitingThis study tests an experimental drug called LP-005, given as an injection into the gums, for people with moderate-to-severe gum disease (periodontitis). About 100 adults aged 18-70 will receive either the drug or a placebo to see if it reduces gum inflammation, bleeding, and bon…
Phase: PHASE2 • Sponsor: Longbio Pharma (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis study tests an experimental tablet called SYH2059 in 156 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing harder. Participants will receive either the drug or a placebo to see if it can slow the decline in lung function. The…
Phase: PHASE2 • Sponsor: InnovStone Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Ginger supplement tested to fight heart disease inflammation
Disease control Not yet recruitingThis study will test whether taking ginger supplements for two months can lower inflammation and oxidative stress in people with coronary artery disease. Fifty adults with confirmed heart disease will be randomly assigned to receive either ginger extract or a placebo. Researchers…
Phase: NA • Sponsor: Universidade Federal Fluminense • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New eczema cream shows promise in major trial
Disease control Not yet recruitingThis study tests a new cream called VC005 for people aged 12 and older with mild to moderate atopic dermatitis (eczema). The goal is to see if the cream can clear or nearly clear the skin rash better than a cream without medicine. About 360 participants will use either the study …
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a High-Protein, High-Fiber diet tame ulcerative colitis?
Disease control Not yet recruitingThis study will test whether a diet rich in protein and fiber can reduce harmful gas-producing bacteria in the gut of people with ulcerative colitis. Forty adults with mild to moderate disease will eat specially prepared frozen meals for two separate week-long periods. Researcher…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New shot could help thyroid patients who Don't respond to usual pills
Disease control Not yet recruitingThis study tests an investigational drug called efgartigimod for adults with Graves' disease whose thyroid levels are still high despite taking standard antithyroid medications. About 230 participants will receive either the drug or a placebo as a shot under the skin. The goal is…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Bee power: could royal jelly and propolis soothe heart inflammation?
Disease control Not yet recruitingThis study looks at whether taking royal jelly and propolis (natural bee products) for two months can lower inflammation and improve heart health in 50 adults with coronary artery disease. Participants will be randomly assigned to receive the supplements or a placebo, and researc…
Phase: NA • Sponsor: Universidade Federal Fluminense • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Sound waves and bubbles take on stubborn joint infections
Disease control Not yet recruitingThis study tests a new way to treat infected knee replacements. About 100 adults having surgery for an infected knee will be randomly assigned to receive either standard care or standard care plus an extra treatment. The extra treatment involves injecting antibiotics along with s…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New cream could help kids with vitiligo regain skin color
Disease control Not yet recruitingThis study tests a cream called ruxolitinib on children aged 2 to 11 with a common type of vitiligo (white patches on skin). The goal is to see if the cream can safely bring back skin color over 24 weeks. About 20 children will apply the cream daily and visit the clinic for check…
Phase: PHASE3 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can stem cell mist heal lungs damaged by cancer immunotherapy?
Disease control Not yet recruitingThis early-phase trial tests whether inhaling tiny particles from stem cells (exosomes) can help heal lung inflammation caused by immunotherapy drugs. The study involves 40 adults with cancer who have persistent lung problems despite standard steroid treatment. Participants will …
Phase: PHASE1, PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to tame autoimmune hepatitis and cut steroid use
Disease control Not yet recruitingThis study tests a drug called inebilizumab in 180 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. The goal is to see if the drug can reduce liver inflammation and allow patients to take lower doses of steroids. Participants will receive e…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Off-the-Shelf CAR-Ts take on lupus and more
Disease control Not yet recruitingThis early-phase trial tests a single dose of universal (off-the-shelf) CAR-T cells in 30 adults with active autoimmune diseases like lupus, scleroderma, vasculitis, myositis, or Sjögren's. The treatment targets CD19 and BCMA on immune cells to reset the faulty immune system. The…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Ancient chewing stick may beat toothbrush for gum health
Disease control Not yet recruitingThis early study will test whether using a miswak chewing stick (from the Salvadora persica plant) can reduce gum inflammation better than a regular toothbrush in people with moderate gum disease (periodontitis). Researchers will measure inflammatory markers in gum fluid from 24 …
Phase: EARLY_PHASE1 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New IPF drug candidate enters first human safety trial
Disease control Not yet recruitingThis early-stage trial tests a new tablet called HW241045 in 102 healthy volunteers to see if it is safe and how the body processes it. The drug is being developed for idiopathic pulmonary fibrosis, a lung-scarring disease. The study is randomized, double-blind, and placebo-contr…
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug MTM-H-001 targets B-Cell autoimmune diseases in early trial
Disease control Not yet recruitingThis early study tests a new drug called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases, including lupus, multiple sclerosis, and rheumatoid arthritis. The main goal is to check safety and find the right dose. Participants receive the drug by injection, and resear…
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a 'Vaginal microbiome Transplant' stop recurring BV?
Disease control Not yet recruitingThis phase 2 trial tests whether transferring vaginal fluid from healthy donors can help women aged 18-25 with recurrent bacterial vaginosis (BV). Participants first receive standard antibiotics, then the transplant. The goal is to see if this restores a healthy vaginal microbiom…
Phase: PHASE2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Ultrasound may solve arthritis diagnosis puzzle
Diagnosis Not yet recruitingRheumatoid arthritis and gout can look alike, making them hard to tell apart early. This study will use ultrasound to see if it can reliably distinguish between the two conditions. Researchers will examine 100 adults with suspected or confirmed arthritis, scoring joint inflammati…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New Pill-Sized device could prevent dangerous blockages during gut scans
Diagnosis Not yet recruitingThis study tests a special capsule that patients swallow to check if their intestines are clear enough for a standard camera capsule. About 25 people with known or suspected intestinal narrowing will take part. They will swallow the patency capsule and get an X-ray within 30 hour…
Phase: NA • Sponsor: AnX Robotica Corp. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Urine test may replace colonoscopy for colitis patients
Diagnosis Not yet recruitingThis study looks at whether a substance in urine, called PGE-MUM, can show if ulcerative colitis is active or in remission. Researchers will collect urine and blood samples from 114 adults with confirmed ulcerative colitis and compare the results with colonoscopy findings. If suc…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
AI stethoscope aims to cut unnecessary antibiotics in kids with cough
Diagnosis Not yet recruitingThis study tests whether an AI-powered digital stethoscope can help health workers more accurately diagnose pneumonia in children aged 2 months to 5 years. 350 children with cough or breathing difficulty will be randomly assigned to standard care or care plus the AI stethoscope. …
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New scan aims to tell two types of hand arthritis apart
Diagnosis Not yet recruitingThis study tests a special imaging agent (99mTc-NTP 15-5) to see if it can spot arthritis-damaged joints in the hands and tell the difference between osteoarthritis and rheumatoid arthritis. About 80 adults with one of these conditions will get a scan. The goal is to improve diag…
Phase: PHASE2 • Sponsor: Centre Jean Perrin • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New Total-Body PET scanner could revolutionize vasculitis diagnosis
Diagnosis Not yet recruitingThis study will test a new type of PET/CT scanner, called Long-Axial Field-of-View (LAFOV), to see if it can provide clearer images of blood vessel inflammation in people with large vessel vasculitis (LVV). The scanner is more sensitive and can image the whole body faster, potent…
Phase: NA • Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
AI tool aims to cut allergy misdiagnosis in primary care
Diagnosis Not yet recruitingThis study tests whether AI-powered decision trees can help general practitioners better diagnose and manage allergies. About 600 patients with suspected allergies will be enrolled, and doctors will use an app that suggests next steps based on symptoms. The goal is to see if this…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Could your Child's cough help diagnose asthma or pneumonia?
Diagnosis Not yet recruitingThis study will collect cough sounds, breath sounds, and symptom questionnaires from 1,400 children with respiratory symptoms like cough or fever. Researchers will use this data to build a computer model that can help diagnose conditions like asthma and pneumonia. The goal is to …
Sponsor: Shanghai Children's Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New AI reads eye scans to diagnose dry eye instantly
Diagnosis Not yet recruitingThis study aims to create an artificial intelligence system that can automatically analyze confocal microscopy images of the cornea to diagnose dry eye disease. Researchers will collect eye scans from 75 adults (healthy and with dry eye) to train and test the AI. The goal is to r…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
AI could revolutionize heart disease screening in poor regions
Diagnosis Not yet recruitingThis study tests whether an AI tool called RADAR can help nurses in low-resource settings detect rheumatic heart disease more accurately using echocardiography. The goal is to make screening easier to scale up worldwide. The trial will enroll 62 nurse screeners at participating f…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Fast new swab test could speed up vaginitis diagnosis
Diagnosis Not yet recruitingThis study will test a new diagnostic device called the Nanopath assay, which aims to quickly detect bacteria or yeast causing vaginitis. Up to 1000 women with symptoms like itching or discharge will provide vaginal swab samples, either collected by a clinician or themselves. The…
Sponsor: Nanopath, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingThis study tests whether a daily probiotic supplement called Colipral® can prevent repeat bladder infections (cystitis) in menopausal women aged 55–70. Participants take either the probiotic or a placebo for 12 weeks and are monitored for 24 weeks to see if they have fewer infect…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Could a Mitochondria-Boosting supplement beat multivitamins for preventing colds?
Prevention Not yet recruitingThis study tests whether a special combination of supplements (sodium nucleinate, magnesium, vitamin B6, and high-dose vitamin D) can prevent respiratory infections like colds and flu better than standard multivitamins. Two hundred healthy male military recruits in Kazakhstan wil…
Phase: NA • Sponsor: MIPO Clinic • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Light therapy may shield kids with cancer from chemo mouth sores
Prevention Not yet recruitingThis study tests whether light therapy (photobiomodulation) can prevent mouth sores in children receiving chemotherapy. Fifty children aged 0-30 will receive daily light treatments during hospital stays and at home. Researchers will check if the therapy is easy to use and accepta…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Common painkiller may prevent pancreatitis after bile duct procedure
Prevention Not yet recruitingThis trial tests whether a single dose of rectal indomethacin, a common anti-inflammatory drug, can prevent pancreatitis in patients undergoing a bile duct procedure (ERCP) who have had a prior sphincterotomy. About 860 adults will be randomly assigned to receive the drug or no d…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple vaccine keep COPD patients out of the hospital?
Prevention Not yet recruitingThis large trial will study whether flu and pneumonia vaccines can reduce serious flare-ups and medical costs in people aged 45-80 with COPD. About 7,000 participants will be split into four groups: flu vaccine, pneumonia vaccine, both, or no vaccine. Researchers will track lung …
Phase: PHASE4 • Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Can light be the new shield against radiation mouth sores?
Prevention Not yet recruitingThis pilot study tests two light therapy devices—one placed inside the mouth and one outside—to prevent and treat painful mouth sores caused by radiation therapy. Sixty adults with oral cavity or oropharynx cancer will receive light sessions twice a week for prevention, then thre…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Can a lower dose of antibiotics prevent pneumonia just as well after kidney transplant?
Prevention Not yet recruitingThis study tests whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose to prevent a serious lung infection called PJP in people who have just had a kidney transplant. About 1,084 adult first-time kidney transplant recipients will take either a low or s…
Phase: PHASE4 • Sponsor: Anhui Provincial Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could ozempic stop pancreatitis from coming back?
Prevention Not yet recruitingThis study tests whether semaglutide (Ozempic/Wegovy) can prevent repeat episodes of acute pancreatitis caused by very high triglycerides. About 396 adults who recently had such an attack will receive either semaglutide injections or a placebo for 18 months, alongside standard ca…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Herbal supplement cistanche tested for explosive power and recovery in athletes
Symptom relief Not yet recruitingThis study tested whether taking a cistanche supplement for 8 weeks, along with a supervised training program, improves anaerobic exercise performance and recovery in young men. 56 men aged 18-25, either elite or amateur athletes, were randomly assigned to receive cistanche extra…
Phase: NA • Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple supplement boost knee injection results for arthritis sufferers?
Symptom relief Not yet recruitingThis study tests whether adding an oral supplement (PEA) to a series of knee injections (adelmidrol and hyaluronic acid) can better reduce pain and improve function in people with knee arthritis. The injections aim to protect the joint from damage, while the supplement may help c…
Phase: NA • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app help tame IBD symptoms?
Symptom relief Not yet recruitingThis pilot study will test a 24-week digital self-management program designed to help people with inflammatory bowel disease (IBD) manage their symptoms and build long-term healthy habits. The program is accessed via web or mobile device and is used alongside standard care. The s…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New pill aims to stop chronic hives fast when antihistamines fail
Symptom relief Not yet recruitingThis early-phase trial tests a new drug called TLL-018 in 36 adults with moderate-to-severe chronic spontaneous urticaria (hives) that standard antihistamines can't control. The goal is to see how quickly TLL-018 reduces itching and hives after the first dose. Participants will r…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Simple pressure check may spare kids from post-surgery sore throat
Symptom relief Not yet recruitingThis study compares two ways of adjusting the air cushion (cuff) on the breathing tube used during general anesthesia in children having laparoscopic appendectomy. One group uses the standard finger-palpation method, while the other uses a pressure sensor to keep the cuff within …
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New injection could ease pain after knee replacement
Symptom relief Not yet recruitingThis study tests whether adding a simple numbing injection (SSSI) to standard pain blocks can better control pain after knee replacement surgery. About 90 adults aged 45-90 will be randomly assigned to receive either the extra injection or a sham (fake) one. The main goal is to s…
Phase: NA • Sponsor: Taipei Medical University WanFang Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New cream with plant extract aims to heal Incontinence-Related skin damage
Symptom relief Not yet recruitingThis study tests a new barrier cream (Dermategrity "Anti-fecal" Barrier Cream) that contains zinc oxide and a natural plant extract to protect and heal skin damaged by incontinence. Sixty adults with incontinence-associated dermatitis will receive either the new cream or a standa…
Phase: NA • Sponsor: Scotiaderm • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New eye drop aims to soothe dry eyes from too much screen time
Symptom relief Not yet recruitingThis study compares a new eye drop (perfluorohexyloctane) with a standard one (sodium hyaluronate) for people whose eyes get dry from using screens for more than 6 hours a day. Participants aged 18 to 70 with mild to moderate dry eye will use the drops four times daily for 8 week…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New injection could tame teen hay fever
Symptom relief Not yet recruitingThis study tests whether an injection called stapokibart can reduce nasal allergy symptoms like runny nose, congestion, sneezing, and itching in adolescents aged 12 to 17 with seasonal allergic rhinitis (hay fever). Participants receive either stapokibart or a placebo alongside t…
Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to cut opioid use after knee replacement with targeted nerve blocks
Symptom relief Not yet recruitingThis trial compares three ways to manage pain after total knee replacement. All patients receive standard nerve blocks, but some also get an anti-inflammatory drug (dexamethasone) or a combination of dexamethasone and a sedative (dexmedetomidine). The goal is to see which approac…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a new skincare trio beat acne? virtual trial seeks answers
Symptom relief Not yet recruitingThis virtual clinical trial will test whether GenLabs' Social Skin products—a cleanser, serum, and cream—can improve acne symptoms and help skin heal better than a placebo. About 150 healthy adults aged 18 to 65 with acne will use the products for 30 days. The main goal is to see…
Phase: NA • Sponsor: GenCanna Acquisition Corp • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Experimental antibodies aim to block cat allergy eye itch
Symptom relief Not yet recruitingThis study tests whether two experimental antibodies, given alone or together, can reduce eye allergy symptoms caused by cat dander. About 570 adults and children aged 8 and older with confirmed cat allergy will receive either the antibodies or a placebo. The main goal is to see …
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a cold rinse during root canals ease Post-Procedure pain?
Symptom relief Not yet recruitingThis study tests whether using very cold water (around 2-3°C) to rinse the inside of a tooth during a root canal can lower pain afterward. The trial includes adults aged 20-40 with painful, infected lower molars. Participants are randomly assigned to receive either cold rinses th…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Laser light could ease knee arthritis without drugs or surgery
Symptom relief Not yet recruitingThis study investigates whether adding High-Intensity Laser Therapy (HILT) to standard physiotherapy helps people with mild-to-moderate knee osteoarthritis. Seventy-two participants will receive either real or sham laser sessions alongside exercise-based physiotherapy. Researcher…
Phase: NA • Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New knee pain treatment approach tested in pilot study
Symptom relief Not yet recruitingThis pilot study compares two standard-of-care radiofrequency ablation (RFA) techniques for chronic knee pain caused by osteoarthritis. Adults already scheduled for knee RFA are randomly assigned to receive either a standard 3-target or a novel 6-target nerve ablation protocol. T…
Phase: NA • Sponsor: Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Knee injection pain: does needle size or a chill spray help?
Symptom relief Not yet recruitingThis study looks at ways to reduce pain during knee steroid injections for osteoarthritis. Researchers will test if using a thinner needle or a numbing spray (ethyl chloride) makes the injection hurt less. 88 adults with knee osteoarthritis will rate their pain right after the sh…
Phase: PHASE4 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Shock waves could soothe sore knees without surgery
Symptom relief Not yet recruitingThis study tests whether adding shock wave therapy to a knee strengthening exercise program reduces pain and improves function more than exercise alone in people with knee osteoarthritis. Forty patients with moderate knee pain will be randomly assigned to either exercise only or …
Phase: NA • Sponsor: Guadarrama Hospital • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a 2-Hour online class ease IBD pain?
Symptom relief Not yet recruitingThis study tests two online pain education programs for adults with Crohn's disease or ulcerative colitis who have chronic pain. Participants will complete a 2-hour online session and report their pain and quality of life weekly for 8 weeks. The goal is to see if these programs a…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a smart vaginal wand ease bladder pain without drugs?
Symptom relief Not yet recruitingThis study tests a new at-home device called the Floora Pelvic Rehabilitation Vaginal Dilator in 10 women with interstitial cystitis (painful bladder syndrome) and high-tone pelvic floor dysfunction. Participants use the device three times a week for 12 weeks, combining heat and …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New lozenge aims to ease radiation mouth sores for hours
Symptom relief Not yet recruitingThis phase 3 trial tests whether a lozenge called BupiZenge, which contains the long-acting painkiller bupivacaine, can relieve mouth pain from radiation therapy better than the standard lidocaine rinse. About 150 adults with head and neck cancer will be randomly assigned to one …
Phase: PHASE3 • Sponsor: OncoZenge AB • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a painkiller stop the cough that Won't quit in lung fibrosis?
Symptom relief Not yet recruitingThis study tests whether an extended-release form of nalbuphine, a pain medication, can safely reduce chronic coughing in people with idiopathic pulmonary fibrosis (IPF), a lung scarring disease. About 306 adults with IPF and a cough lasting at least 8 weeks will receive either t…
Phase: PHASE3 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a common painkiller speed up cellulitis recovery?
Symptom relief Not yet recruitingCellulitis is a painful bacterial skin infection. This study tests whether adding naproxen (an anti-inflammatory drug) to standard antibiotics helps reduce redness and pain faster than antibiotics alone. About 884 adults with cellulitis will take either naproxen or a placebo for …
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Can a phone app help RA patients feel less anxious?
Symptom relief Not yet recruitingThis study tests whether an 8-week program of yoga and meditation delivered through a mobile app can reduce anxiety in adults with stable rheumatoid arthritis. About 100 participants will either use the app daily or continue with standard care. Researchers will measure changes in…
Phase: NA • Sponsor: Tugba Civi Karaaslan • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Chill after the drill: could cold saline soothe root canal pain?
Symptom relief Not yet recruitingThis study looks at whether using a cold saline rinse after ultrasonic cleaning during a root canal can lower pain afterward. Adults with an inflamed tooth nerve will get either ultrasonic cleaning alone or followed by a cold saline flush. Pain levels are tracked for three days a…
Phase: NA • Sponsor: Dr Arsalan Ali Khan • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Laser vs. electric patch: which eases knee pain best?
Symptom relief Not yet recruitingThis study will compare two treatments—low-level laser therapy and iontophoresis (a method that uses a mild electric current to deliver medication through the skin)—for knee osteoarthritis. Sixty-six adults aged 45 to 65 with mild to moderate knee arthritis will be randomly assig…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Keto diet tested to fight muscle loss in hospitalized pneumonia patients
Symptom relief Not yet recruitingThis study tests whether a ketogenic diet (low carb, high fat) is better than a standard diet at preserving muscle function in older adults hospitalized with pneumonia. Researchers will enroll 30 patients aged 55 and older and measure handgrip strength and diet adherence. The goa…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common muscle relaxant cut narcotic use after hysterectomy?
Symptom relief Not yet recruitingThis study tests whether adding cyclobenzaprine, a muscle relaxant, to standard pain medicines (ibuprofen, acetaminophen, and short-term narcotics) improves pain control and reduces narcotic use after minimally invasive hysterectomy. About 36 women undergoing laparoscopic hystere…
Phase: PHASE4 • Sponsor: Christiana Care Health Services • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Which probiotic stops Kids' diarrhea faster? new trial aims to find out
Symptom relief Not yet recruitingThis study will compare two probiotic drinks—Bacillus clausii and a mix of four bacterial strains—in 138 children aged 1 to 5 with acute watery diarrhea. All children will also receive standard care like rehydration and zinc. The goal is to see which probiotic reduces diarrhea du…
Phase: NA • Sponsor: Children Hospital and Institute of Child Health, Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Bladder gel shots aim to ease chronic pelvic pain
Symptom relief Not yet recruitingThis pilot study tests whether injecting hyaluronic acid directly into the bladder wall is safe and can reduce pain and frequent urination in people with interstitial cystitis (bladder pain syndrome). Fifteen adults who haven't improved after standard treatments will receive the …
Phase: PHASE1 • Sponsor: Sverdlovsk Regional Clinical Hospital No.1 • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New eye drop aims to soothe dry eyes Long-Term
Symptom relief Not yet recruitingThis study tests whether acoltremon eye drops can improve symptoms and tear production in people with dry eye disease over 12 months. Sixty adults will be randomly assigned to receive either the active drug or a standard artificial tear. Researchers will track changes in eye disc…
Sponsor: The Eye Care Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Zoom yoga for young arthritis patients: a new hope?
Symptom relief Not yet recruitingThis study will test whether an 8-week yoga program done live over Zoom can improve balance, endurance, and well-being in 32 children aged 8-12 with juvenile idiopathic arthritis (JIA). The yoga sessions are led by certified physiotherapists and include breathing, poses, and medi…
Phase: NA • Sponsor: Akdeniz University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Heel pain breakthrough? new study pits needle therapy against surgery
Symptom relief Not yet recruitingThis study compares a 6-week non-surgical treatment (manual therapy plus nerve stimulation) with surgery for people who have had heel pain for over 6 months and haven't gotten better with standard care. 120 adults aged 30-65 will choose their preferred treatment and be followed f…
Phase: NA • Sponsor: Universidad Europea de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app ease the Gut-Brain struggle for IBD patients?
Symptom relief Not yet recruitingThis study tests a mobile app designed to help Black and Hispanic adults with inflammatory bowel disease (IBD) manage stress and improve their quality of life. The app teaches coping skills, mindfulness, and disease acceptance. Researchers want to see if the app is practical and …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Shockwave or laser: the battle to end tennis elbow pain
Symptom relief Not yet recruitingThis study compares two non-surgical treatments—shockwave therapy and high-power laser—for chronic tennis elbow (lateral epicondylitis) that has lasted over 3 months. Seventy-two adults aged 40-50 will receive one of the treatments plus standard physical therapy. Researchers will…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests nerve stretching to ease heel pain
Symptom relief Not yet recruitingThis study will compare two types of nerve mobilization added to standard physical therapy for chronic plantar fasciitis. Sixty adults with heel pain for at least six weeks will be randomly assigned to receive either posterior tibial nerve mobilization or saphenous nerve mobiliza…
Phase: NA • Sponsor: Prince Sattam Bin Abdulaziz University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a daily yogurt soothe your gallbladder?
Symptom relief Not yet recruitingThis study tests whether a special yogurt containing the probiotic Pediococcus acidilactici GR-5 can help people with chronic cholecystitis (long-term gallbladder inflammation). Fifty adults with the condition will eat either the probiotic yogurt or a regular placebo yogurt daily…
Phase: NA • Sponsor: LanZhou University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Spa therapy for knee pain: new study tests if heat and water help movement
Symptom relief Not yet recruitingThis study will follow 300 adults aged 50 and older with knee osteoarthritis who are scheduled for a 3-week thermal spa treatment. Researchers will use wearable sensors to measure knee movement fluidity before and after the spa program, and at 3 and 12 months later. They will als…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Dry eye gel may sharpen cataract surgery results
Symptom relief Not yet recruitingThis study looks at whether a gel-like filler placed in the tear ducts can improve dry eye symptoms and make eye measurements more accurate before cataract surgery. About 65 adults with dry eye disease will be observed. The goal is to see if treating dry eye first leads to better…
Sponsor: The Eye Institute of West Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Gym membership vs. physio: which works better for knee pain?
Symptom relief Not yet recruitingThis study compares two ways to manage knee osteoarthritis: doing your own exercise at a local fitness center versus supervised sessions with a physiotherapist. Researchers want to see if the cheaper, more flexible gym option is just as good at reducing pain and improving quality…
Phase: NA • Sponsor: Marius Henriksen • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app heal the hidden wounds of the ICU?
Symptom relief Not yet recruitingThis study tests a mobile mindfulness program called Lift for people who survived a serious illness in the ICU and now struggle with depression, anxiety, or stress. About 450 adults will use either the Lift app or a health education app for 6 months. The goal is to see if the min…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a pill plus walking ease knee pain and lift mood in veterans?
Symptom relief Not yet recruitingThis study tests whether combining the medication duloxetine with a structured walking program can improve physical function, reduce pain, and ease depressive symptoms in veterans with knee osteoarthritis. Participants will be assigned to either the drug-plus-exercise group or a …
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
AI coach may soothe radiation skin burns in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether an artificial intelligence-powered digital education program can reduce the severity of radiodermatitis (skin irritation from radiation) and improve quality of life in women with breast cancer. 38 patients will be randomly assigned to either receive the A…
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Walking backwards could be a simple way to ease knee arthritis pain
Symptom relief Not yet recruitingThis study tests whether walking backwards on a treadmill (called retro walking) can help reduce pain and improve how people with knee osteoarthritis walk. Participants will do retro walking sessions, starting with 10 minutes and gradually increasing up to 30 minutes if pain stay…
Phase: NA • Sponsor: Anglia Ruskin University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Ice chips vs. mouth sores: simple trick may ease chemo side effect
Symptom relief Not yet recruitingThis study tests whether sucking on ice chips during chemotherapy can prevent or reduce the severity of painful mouth sores (oral mucositis) in cancer patients. 102 adults receiving 5-fluorouracil or methotrexate will be randomly assigned to either get ice chips during infusion p…
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
CBD oil for aching knees? new study seeks answers
Symptom relief Not yet recruitingThis pilot study tests whether a topical CBD oil can reduce pain in people with knee osteoarthritis. Thirty participants will apply either CBD in castor oil or plain castor oil to their knees twice daily for 30 days, then switch treatments. Researchers will track pain scores and …
Phase: PHASE2 • Sponsor: University of Tennessee • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Dry eye sufferers: are preservatives in your eye drops making things worse?
Symptom relief Not yet recruitingThis study compares two types of artificial tears for dry eye disease: one with preservatives and one without. Researchers want to see which is safer and more effective over 8 weeks. About 80 adults with dry eye will take part, and neither they nor their doctors will know which t…
Phase: PHASE4 • Sponsor: Pokhara Academy of Health Sciences, Western Regional Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Freezing pain away: yale tests Nerve-Blocking procedure for Long-Term relief
Symptom relief Not yet recruitingThis study will follow 80 people with chronic pain (like back, hip, or nerve pain) who are getting a procedure called cryoneurolysis, which uses cold to temporarily block pain signals. Researchers want to see if it leads to meaningful pain relief and better daily function over 12…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops could bring relief to millions with chronic dry eye
Symptom relief Not yet recruitingThis Phase 3 trial tests whether CAM-101 eye drops can reduce eye discomfort and corneal damage in people with moderate to severe dry eye. About 475 adults will receive either CAM-101 or a placebo for 9 weeks, then all participants can switch to CAM-101 for a year. The study aims…
Phase: PHASE3 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New foam aims to soothe immunotherapy skin side effects
Symptom relief Not yet recruitingThis phase 2 trial tests a medicated foam called roflumilast on skin rashes caused by checkpoint inhibitor cancer drugs. Twenty adults with mild to severe rash will apply the foam daily for 16 weeks. The goal is to see if it safely reduces rash severity and improves quality of li…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Herbal hope: new blend aims to shorten your next cold
Symptom relief Not yet recruitingThis study tests a new herbal blend designed to shorten the duration and reduce the severity of common cold symptoms. Researchers will enroll 300 healthy adults in Australia who get frequent colds. Participants will take the herbal product or a placebo whenever they feel a cold c…
Phase: PHASE2 • Sponsor: RDC Clinical Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Simple shoulder exercises may ease frozen shoulder pain
Symptom relief Not yet recruitingThis study tests if deltoid strengthening exercises can reduce pain and improve movement in people with frozen shoulder (adhesive capsulitis). 48 adults aged 40-60 with stage II or III frozen shoulder will do specific isometric exercises targeting the deltoid muscle. Researchers …
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Robotic vs. manual knee alignment: which is better for heavier patients?
Symptom relief Not yet recruitingThis study compares two ways to align the knee during total knee replacement in 80 obese adults (BMI 35+). One method uses robotic or computer assistance, the other uses traditional manual tools. The goal is to see which leads to better knee motion and recovery after surgery.
Phase: PHASE4 • Sponsor: Jacob M. Elkins • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New oxygen method may prevent dangerous drops during ERCP
Symptom relief Not yet recruitingThis study tests a special oxygen tube placed in the mouth during a procedure called ERCP, which is used to treat bile duct and pancreas problems. The goal is to see if this method can prevent low oxygen levels that often happen when patients are deeply sedated. About 410 adults …
Phase: NA • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New exercise program aims to ease knee pain in seniors
Symptom relief Not yet recruitingThis study tests a physical therapy program designed for older adults with knee osteoarthritis. The program focuses on mobility, balance, and fall prevention, and also considers each person's mental abilities. Forty participants aged 60 and older will take part in 16 sessions ove…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can simple posture exercises ease knee arthritis pain?
Symptom relief Not yet recruitingThis study will test whether Egoscue postural exercises, alone or combined with a hands-on technique called Mobilization with Movement (MWM), can reduce pain, improve balance, and boost quality of life in people with knee osteoarthritis. Researchers plan to enroll 56 adults aged …
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Hospital stay for mild pancreatitis questioned: home care as safe?
Symptom relief Not yet recruitingThis study compares home management versus standard hospital care for people with mild acute pancreatitis. Participants will be randomly assigned to either go home with daily phone check-ins and a clinic visit, or stay in the hospital. The goal is to see if home care is as safe a…
Phase: NA • Sponsor: Center for Traumatology and Major Burns, Ben Arous • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New gel injection aims to ease knee pain without surgery
Symptom relief Not yet recruitingThis study tests whether a gel called Conjuran can reduce pain in people with knee osteoarthritis better than the current standard treatment, Hyruan. About 180 adults with mild to moderate knee arthritis will receive two cycles of injections, each cycle consisting of five weekly …
Phase: NA • Sponsor: PharmaResearch Co.,Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New exercise method may ease knee arthritis pain without surgery
Symptom relief Not yet recruitingThis study tests whether a special exercise method called Sahrmann's approach can reduce pain and improve knee function better than standard physical therapy in people with knee osteoarthritis. Forty adults aged 40 to 60 with moderate knee arthritis will be assigned to one of two…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New eyelid massage tool aims to soothe dry eyes
Symptom relief Not yet recruitingThis study compares a new eyelid support plate to a standard glass rod for eyelid massage in people with dry eye from meibomian gland dysfunction. 142 adults will receive either the new device or standard massage, plus eye drops, over 8 weeks. The goal is to see which method bett…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New pill could ease osteoarthritis knee pain without surgery
Symptom relief Not yet recruitingThis Phase 2 trial tests an experimental oral drug, LY4065967, for knee pain caused by osteoarthritis. About 150 adults with chronic knee pain and confirmed osteoarthritis will receive either the drug or a placebo. The main goal is to see if the drug safely reduces pain intensity…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a daily supplement ease knee arthritis pain?
Symptom relief Not yet recruitingThis study will test Mobithron Xtra, an oral supplement containing hyaluronic acid, collagen, and Boswellia extract, in 100 adults with knee osteoarthritis. Participants will take it once daily for 3 months while researchers track changes in pain, stiffness, and daily function us…
Sponsor: University of Malaya • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New pain shot may cut opioid use after knee replacement
Symptom relief Not yet recruitingThis study compares two pain relief methods after total knee replacement: a long-acting pain shot (Zynrelef) given directly into the knee during surgery versus a standard nerve block. The goal is to see which method better reduces the need for opioid painkillers in the first 72 h…
Phase: PHASE4 • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a special gel soothe your gums? new study aims to find out
Symptom relief Not yet recruitingThis pilot study will test whether a dental gel called theranovis can improve gum health in people with gingivitis (mild gum disease). Twenty adults with gingivitis will use either the gel or a placebo twice daily for a period. Researchers will measure changes in gum bleeding and…
Phase: NA • Sponsor: Medical University of Graz • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New exercise combo may boost heart attack recovery
Symptom relief Not yet recruitingThis study tests if combining arm and leg cycling exercise is better than leg cycling alone for improving fitness and quality of life in people who have had a heart attack. Forty medically stable adults aged 40-70 will exercise three times a week for six weeks. Researchers will m…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Bone marrow injection may offer longer hip pain relief than steroids
Symptom relief Not yet recruitingThis study tests whether a single injection of concentrated bone marrow cells can reduce pain and improve function in people with hip osteoarthritis better than a standard steroid injection. One hundred adults with moderate to severe hip arthritis will be randomly assigned to rec…
Phase: PHASE3 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Hands-On therapy may spare kids from ear tube surgery
Symptom relief Not yet recruitingThis study tests whether osteopathic manipulative treatment (OMT) — a gentle, hands-on therapy — can reduce the need for ear tube surgery in children with chronic or recurrent ear infections. Two hundred children aged 6 months to 7 years will receive either OMT or a placebo manua…
Phase: NA • Sponsor: Sarah Vidal • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a special diet tame ulcerative colitis? breath tests may tell
Symptom relief Not yet recruitingThis study tests whether a short liquid diet followed by a low-sulfur eating plan is safe and helpful for people with mild to moderate ulcerative colitis. Researchers will check if this approach improves gut health, lowers inflammation, and eases symptoms. They will also use brea…
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a steroid eye drop help heal corneal ulcers faster?
Symptom relief Not yet recruitingThis phase 2 trial tests whether adding a steroid eye drop (fluorometholone) to standard antibiotic treatment improves vision at 3 months in people with bacterial corneal ulcers. About 174 adults with mild to severe ulcers will be randomly assigned to get either the steroid plus …
Phase: PHASE2 • Sponsor: Vishal Jhanji • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Hands-On healing: new study tests OMT for frozen shoulder relief
Symptom relief Not yet recruitingThis study tests whether adding Osteopathic Manipulative Treatment (OMT) — a non-invasive, hands-on therapy — to standard care helps people with frozen shoulder recover faster and feel more satisfied. About 300 adults who have not yet been treated for frozen shoulder will be assi…
Phase: PHASE4 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New heat therapy could ease knee pain without surgery
Symptom relief Not yet recruitingThis study tests whether TECAR therapy—a device that delivers gentle heat deep into the knee—can reduce pain, improve balance, and boost quality of life in elderly men with knee osteoarthritis. Eighty men will receive either real TECAR plus standard physiotherapy or a sham versio…
Phase: NA • Sponsor: Middle East University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
3D-Printed hand braces could be cheaper and just as effective
Symptom relief Not yet recruitingThis study compares 3D-printed hand orthoses (braces) to traditional custom-made ones in 100 adults with chronic hand conditions from nerve, muscle, or bone issues. The goal is to see if the 3D-printed versions work just as well for daily activities, are more satisfying, and cost…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Salt shaker showdown: could less sodium mean less eczema itch?
Symptom relief Not yet recruitingThis study looks at whether lowering salt in your diet can make eczema less severe. Forty adults with eczema will eat a low-salt diet for 24 weeks. For 5 weeks they'll take salt pills, and for another 5 weeks they'll take placebo pills, to see the real effect of sodium. Researche…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New hip surgery technique may get you back on your feet faster
Symptom relief Not yet recruitingThis study compares two ways to perform total hip replacement: the standard direct lateral approach and a newer, less invasive method called SuperPATH. Researchers want to see if SuperPATH reduces pain, blood loss, and recovery time while improving joint stability. 100 adults nee…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could a common drug ease psoriasis? new study seeks answers
Symptom relief Not yet recruitingThis study tests whether adding a pill called pentoxifylline to standard skin creams can improve mild-to-moderate psoriasis. About 140 adults will take either the study drug or a placebo twice daily for 12 weeks. Researchers will measure changes in skin severity, itch, and qualit…
Phase: NA • Sponsor: Wasuchon Chaichan • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can acne pills soothe cancer Treatment's skin side effect?
Symptom relief Not yet recruitingThis study tests whether isotretinoin or doxycycline works better for treating an acne-like rash that can appear in people taking certain cancer drugs. About 50 participants who already have a moderate to severe rash will receive one of the two medications. The goal is to see whi…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New eye drop aims to soothe dry, irritated eyes
Symptom relief Not yet recruitingThis study tests an experimental eye drop called RCI001 in 200 adults with dry eye disease. Participants will use the drops or a placebo for 4 weeks. The goal is to see if RCI001 reduces eye discomfort and damage to the eye's surface better than placebo. The study is not yet recr…
Phase: PHASE2 • Sponsor: Rudacure • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Shock wave showdown: how many sessions to soothe heel pain?
Symptom relief Not yet recruitingThis study looks at whether having more sessions of shock wave therapy (ESWT) helps people with long-term heel pain (plantar fasciitis) feel better and move easier. About 57 adults with pain lasting at least 3 months will be split into groups getting different numbers of ESWT ses…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Short steroid course after joint surgery could ease recovery, new trial to test
Symptom relief Not yet recruitingThis study will test whether taking prednisone for 5 days after knee or hip replacement surgery helps reduce pain, swelling, and the need for opioids compared to the standard steroid given only during surgery. About 104 adults will participate, and their blood sugar will be track…
Phase: PHASE4 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New syrup aims to soothe coughs in just two days
Symptom relief Not yet recruitingThis study looks at how well and how safely SIROPSEDAL syrup works for acute cough caused by colds or upper respiratory infections. About 124 children and adults will take the syrup as prescribed by their doctor and report their cough severity over one week. The main goal is to s…
Sponsor: Laboratoires Elerte • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Which anesthetic gets you home faster after hip surgery?
Symptom relief Not yet recruitingThis study compares two spinal anesthetics, ropivacaine and bupivacaine, in 176 people having hip replacement surgery. The goal is to see which one allows faster return of feeling and movement while still controlling pain well enough for same-day discharge.
Phase: PHASE4 • Sponsor: University of Turku • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Tyler twist or eccentric moves: which eases tennis elbow better?
Symptom relief Not yet recruitingThis study compares two exercise programs—the Tyler Twist and traditional eccentric exercises—for people with tennis elbow (lateral epicondylalgia). Researchers will measure pain, grip strength, and daily function in 38 adults aged 20 to 40. The goal is to find which approach pro…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Antibiotics may not be needed for mild diverticulitis, new US trial suggests
Symptom relief Not yet recruitingThis trial tests whether people with mild diverticulitis can be safely treated at home with just pain medicines (ibuprofen and acetaminophen) instead of antibiotics. 556 participants will be randomly assigned to receive either pain medicines alone or pain medicines plus an antibi…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can a 10-Day exercise boost before knee surgery speed recovery?
Symptom relief Not yet recruitingThis study tests whether a short, digitally guided exercise program before total knee replacement is practical and helpful. Sixty adults with knee osteoarthritis will either do the 10-14 day program or receive usual care. The main goal is to see if people stick with it and find i…
Phase: NA • Sponsor: Ludwig Boltzmann Institute for Digital Health and Prevention • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
AI app could replace physiotherapist for knee pain relief
Symptom relief Not yet recruitingThis study tests whether an AI-powered app can guide people with knee osteoarthritis through exercises at home, reducing pain and improving function as well as in-person physiotherapy. About 176 adults aged 50 and older with knee pain will be split into two groups: one receiving …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Talking your way to healthier gums: study tests motivational interviewing for periodontitis
Symptom relief Not yet recruitingThis study tests whether motivational interviewing, a patient-centered counseling approach, can improve outcomes of standard gum disease treatment (subgingival instrumentation) in 66 adults aged 30-50 with periodontitis. Participants will receive either motivational interviewing …
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Root canal relief? study tests weaker bleach for less pain
Symptom relief Not yet recruitingThis study compares two strengths of sodium hypochlorite (a disinfectant used during root canals) to see which causes less pain afterward. 116 adults needing a root canal will be randomly assigned to receive either a 2.5% or 5.25% solution. Pain levels will be measured at 6, 12, …
Phase: NA • Sponsor: College of Physicians and Surgeons Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New shot for teen hay fever? early trial underway
Symptom relief Not yet recruitingThis phase 2 trial tests the safety of stapokibart injection in 15 teenagers aged 12-17 with seasonal allergic rhinitis (hay fever). Participants receive the drug alongside their usual allergy treatments. The study focuses on side effects and how the body processes the drug, not …
Phase: PHASE2 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New drug aims to cut opioid use after knee replacement
Symptom relief Not yet recruitingThis study tests whether adding suzetrigine (Journavx) to standard pain management can lower pain and reduce the need for opioid painkillers after total knee replacement. About 75 adults with knee arthritis will take the drug as part of their post-surgery care. The goal is to imp…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New nasal spray aims to unblock stuffy noses fast
Symptom relief Not yet recruitingThis study looks at how well RHINOSEDAL works for people aged 8 and older with a stuffy nose caused by colds, allergies, or sinus issues. About 126 participants will use the treatment as prescribed and report their symptoms over 6 days. The goal is to see if it provides meaningfu…
Sponsor: Laboratoires Elerte • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New drug aimed at calming the itch of prurigo nodularis enters human testing
Symptom relief Not yet recruitingThis Phase 2 study tests lebrikizumab (Ebglyss) in 15 adults with moderate-to-severe prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants receive injections every two weeks for 24 weeks. The main goals are to measure how much itching decreases …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New pill PG-033 tested for safety in first human trial
Symptom relief Not yet recruitingThis Phase 1 trial will test the safety and tolerability of multiple doses of PG-033 tablets in 30 healthy adults. Participants will be randomly assigned to receive either PG-033 or a placebo. The study aims to find out how the drug moves through the body and whether it causes an…
Phase: PHASE1 • Sponsor: Prime Gene Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Botox shots aim to save limbs in rare Smoker's disease
Symptom relief Not yet recruitingThis study tests whether injecting botulinum toxin (Botox) into the hands or feet can help people with Buerger's disease, a rare condition that blocks blood flow and causes severe pain. Eight adults with critical limb ischemia will receive a single injection session and be follow…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to find best pain relief after knee replacement
Symptom relief Not yet recruitingThis study looks at two different methods to control pain after total knee replacement. One method combines two nerve blocks given by an anesthesiologist, while the other uses a nerve block plus a local painkiller injection by the surgeon. Researchers will review the medical reco…
Sponsor: Turgutlu State Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple roller ease tennis elbow pain without drugs?
Symptom relief Not yet recruitingThis study tests whether a roller device that delivers essential oils during self-massage can reduce pain and improve function in people with chronic tennis elbow (lasting over 3 months). Eighty adults will use the roller twice daily for 3 months. Researchers will measure pain an…
Phase: NA • Sponsor: Puressentiel • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug HRS-3095 aims to soothe stubborn hives
Symptom relief Not yet recruitingThis Phase 2 trial tests whether the experimental drug HRS-3095 can reduce itching and wheals in adults with chronic spontaneous urticaria (hives) that isn't well controlled by antihistamines. About 190 participants will receive either the drug or a placebo daily for 4 weeks. The…
Phase: PHASE2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Laser vs shock waves: which zaps shoulder pain best?
Symptom relief Not yet recruitingThis study compares two non-invasive treatments—high-intensity laser therapy and shock wave therapy—for people with chronic shoulder pain from supraspinatus tendinitis. Researchers will measure pain and disability in 48 adults over several weeks to see which approach works better…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New knee injection polymer put to the test in first human trial
Symptom relief Not yet recruitingThis early study tests the safety of a single injection of a new polymer called ABR1 for knee osteoarthritis. About 25 adults with moderate to severe knee pain will receive the injection and be followed for 12 weeks. The main goal is to see if the treatment causes any side effect…
Phase: NA • Sponsor: Pleryon Therapeutics (Hangzhou) Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Iron pills may ease eczema in teens, new study hopes to prove
Symptom relief Not yet recruitingThis study tests whether adding oral iron supplements to standard eczema treatment can reduce skin symptoms and improve quality of life in adolescents aged 12 to 16 with mild to moderate atopic dermatitis. Researchers will also check if iron levels in the blood affect how well th…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Gum disease breakthrough? behavioral coaching may boost treatment success
Symptom relief Not yet recruitingThis study tests whether a special behavioral program can help people with gum disease who lack confidence in their oral hygiene. 78 adults with stage I-III periodontitis will get standard gum treatment plus either the behavioral program or regular instructions. Researchers will …
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Dentists test three sealers to find the most comfortable root canal
Symptom relief Not yet recruitingThis study compares three different root canal sealers—AH Plus, ProRoot Bio Sealer, and BC Sealer ion+—to see which one leads to the least pain after treatment. About 135 adults with irreversible pulpitis in a lower molar will be randomly assigned to one of the three sealers. Pat…
Phase: NA • Sponsor: European University of Lefke • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Timing is everything: new study tests best order for knee pain relief
Symptom relief Not yet recruitingThis study looks at whether using a gentle pulling force (mechanical traction) on the knee before or after exercise works better for easing pain and improving movement in people with knee osteoarthritis. Researchers will compare three groups: traction before exercise, traction af…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can a common gout pill ease pain from this rare joint disease?
Symptom relief Not yet recruitingThis study tests whether colchicine, a drug used for gout, can lower inflammation and pain in people with CPPD disease. About 150 adults will take either colchicine or a placebo daily for 6 months. Researchers will measure blood markers and joint symptoms to see if the drug helps…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Simple moves after heart surgery may save lungs
Symptom relief Not yet recruitingThis study looks at whether changing body position and doing special breathing exercises can help prevent lung issues like pneumonia after heart surgery. About 124 adults having planned heart surgery will be split into four groups: one getting usual care, one doing only breathing…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Empowerment program aims to ease breast cancer treatment stress
Symptom relief Not yet recruitingThis pilot study tests a program called COPE (Creating Opportunities for Personal Empowerment) in 40 women with stage I-III breast cancer who are starting their first treatment. Participants will either receive the 7-week COPE sessions plus standard care, or standard care alone. …
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New brace and exercise combo aims to ease knee arthritis pain
Symptom relief Not yet recruitingThis study tests whether a special knee and heel brace, combined with strength exercises done while sitting or lying down, can reduce pain and improve walking in people with knee osteoarthritis. Twenty participants will be randomly assigned to get either this new brace or a stand…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New shoulder block offers hope for chronic pain sufferers
Symptom relief Not yet recruitingThis study tests a new type of nerve block (PENG block) for people with chronic shoulder pain that hasn't improved with other treatments. 45 adults will get an ultrasound-guided injection of numbing medicine and steroid. Researchers will measure pain, shoulder function, and satis…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Tape it or skip it? new study tests kinesiotaping for knee arthritis
Symptom relief Not yet recruitingThis study looks at whether adding kinesiotaping (a special elastic tape) to standard physical therapy can improve pain, movement, and fear of activity in people with knee osteoarthritis. Sixty adults aged 40-65 with mild knee arthritis will be randomly assigned to receive either…
Phase: NA • Sponsor: Nazli Cigercioglu • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Light therapy offers hope for knee pain sufferers
Symptom relief Not yet recruitingThis study tests whether a special light treatment, called photobiomodulation, can reduce pain and swelling in people with long-term knee osteoarthritis. Researchers will measure pain levels before and after treatment in 30 adults aged 50 and older. The goal is to find a drug-fre…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can an online program help young people with lupus and dermatomyositis feel less stressed?
Symptom relief Not yet recruitingThis study tests a new online program called TEAM-LEADS designed to help teens and young adults (ages 13-22) with lupus or dermatomyositis reduce stress and improve heart-healthy behaviors like diet, exercise, and sleep. The program is self-guided and completed online. The study …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Needle in hand, heel pain gone? new study investigates
Symptom relief Not yet recruitingThis study tests if a specific acupuncture point on the hand can safely reduce heel pain and improve walking. Researchers will treat 150 adults aged 40-70 who have had heel pain for less than two months. The main goal is to see if at least half of participants get significant pai…
Phase: NA • Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New liquid diet could ease stomach pain for pancreatitis patients
Symptom relief Not yet recruitingThis study tests whether a specially designed, better-tasting liquid diet can be used for two weeks by adults with chronic pancreatitis who have bothersome stomach symptoms. The diet is an easy-to-absorb formula that replaces all food for 14 days. Researchers want to see if peopl…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Not yet recruitingThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase: PHASE2, PHASE3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Light therapy offers hope for kids suffering chemo mouth sores
Symptom relief Not yet recruitingThis study tests a painless light treatment called photobiomodulation for children aged 3 to 14 who get severe mouth sores from chemotherapy. The treatment uses a handheld red light device for about 5-10 minutes daily for four days, alongside standard care. Researchers want to se…
Phase: NA • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Virtual reality could replace pills for pain during ENT procedures
Symptom relief Not yet recruitingThis study compares two types of virtual reality (VR) during common ear, nose, and throat (ENT) procedures. One group will watch calming scenery, while the other plays an interactive puzzle game. Researchers want to see which better reduces pain and anxiety. The study will includ…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New gel could soothe eczema symptoms in early trial
Symptom relief Not yet recruitingThis study tests a gel called VC005 on adults with mild to moderate atopic dermatitis (eczema). About 120 participants will use either the gel or a placebo to see if it safely reduces skin redness, itching, and rash. The goal is to ease symptoms, not cure the condition.
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Could a home device ease frozen shoulder pain?
Symptom relief Not yet recruitingThis study looks at whether using a home-based electrical stimulation device, along with standard physical therapy, can help reduce pain and improve shoulder function in people with frozen shoulder. Ten adults diagnosed with the condition will use the device at home while continu…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New allergy spray trial aims to help teens breathe easier
Symptom relief Not yet recruitingThis study tests if Dymista nasal spray safely eases allergy symptoms like sneezing, stuffy nose, and itchy eyes in Chinese teenagers aged 12 to 17. About 100 participants will use the spray twice daily for two weeks. The goal is to see if symptoms improve, not to cure allergies.
Phase: PHASE4 • Sponsor: Viatris Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Partial tonsil surgery may cut sick leave and opioid use
Symptom relief Not yet recruitingThis study compares two tonsil surgery methods in adults: full removal (extracapsular) and partial removal (intracapsular). The goal is to see if partial surgery allows a shorter sick leave and less need for opioid painkillers, while still being as effective at relieving tonsilli…
Phase: NA • Sponsor: Turku University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Algae extract could shield menopausal brains from mental decline
Symptom relief Not yet recruitingThis study tests whether a daily lutein supplement made from microalgae can slow cognitive decline in postmenopausal women with obesity. 300 women aged 48-60 will take either 6 mg, 14 mg, or a placebo for 180 days. Researchers will measure changes in memory, attention, and inflam…
Phase: NA • Sponsor: Poznan University of Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New combo therapy aims to ease knee pain without heavy lifting
Symptom relief Not yet recruitingThis study tests whether combining blood-flow-restricted exercise (light exercise with a cuff on the leg) and pain education can reduce pain and improve movement in people with knee osteoarthritis. About 90 adults aged 40 and older with knee osteoarthritis will take part. The goa…
Phase: NA • Sponsor: University of Hail • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Music and VR tested to soothe kids with leukaemia during painful mouth care
Symptom relief Not yet recruitingThis study tests whether listening to calming music or using virtual reality can reduce pain, anxiety, and fear in children aged 6-12 with leukaemia who need care for painful mouth sores caused by chemotherapy. Forty-five children will be randomly assigned to a music group, a VR …
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Playful breathing exercises may speed recovery for kids with pneumonia
Symptom relief Not yet recruitingThis study tests a child-friendly breathing exercise program for children aged 6-18 recovering from severe pneumonia. The program is designed to be fun and engaging, aiming to improve recovery and make caregivers happier with the care. Researchers will compare kids who do the exe…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Exercise during radiation: a new way to fight inflammation?
Symptom relief Not yet recruitingThis study tests whether moderate aerobic exercise, done during breast cancer radiotherapy, can reduce inflammation and improve physical fitness and quality of life. Forty women with early-stage breast cancer will either do supervised exercise sessions or receive usual care. Rese…
Phase: NA • Sponsor: Universidad Francisco de Vitoria • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Dutch hospital data reveals hidden patterns in IBD treatment
Knowledge-focused Not yet recruitingThis study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other…
Sponsor: LOGEX • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Smartwatches could save young lives in ghana by catching danger signs earlier
Knowledge-focused Not yet recruitingThis study will see if using a Garmin smartwatch to continuously track heart rate, breathing rate, and oxygen levels can help doctors spot early warning signs in hospitalized children in Ghana. About 250 children with traumatic injuries or after appendix surgery will wear the wat…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gut microbes may hold key to diverticular disease
Knowledge-focused Not yet recruitingThis study investigates whether the bacteria living in the gut influence the development of diverticular disease and acute diverticulitis. Researchers will compare the gut microbiota of people with and without these conditions to identify differences and risk factors. The goal is…
Sponsor: Hospital of Navarra • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Acupuncture points may signal hidden disease activity
Knowledge-focused Not yet recruitingThis study investigates whether acupuncture points become tender or more sensitive in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Researchers will compare skin temperature, blood flow, and pain sensitivity at specific body points b…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New drug candidate SCB0020160 enters first human safety tests
Knowledge-focused Not yet recruitingThis phase 1 trial tests a new investigational drug, SCB0020160, for the first time in humans. Healthy adult men aged 18 to 65 receive either the drug or a placebo to evaluate safety, tolerability, and how the drug moves through the body. The study also looks at whether food affe…
Phase: PHASE1 • Sponsor: SCBIO Inc. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Pneumonia culprit may be rarer than doctors think
Knowledge-focused Not yet recruitingThis study looks at 200 people with pneumonia to find out how many actually have an infection caused by Chlamydia pneumoniae, a type of bacteria. Researchers will use PCR tests to check for the germ and compare results with standard care. The goal is to see if this infection is o…
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Dermatology study aims to cut unnecessary clinic visits with simple surveys
Knowledge-focused Not yet recruitingThis study tests whether letting patients report their symptoms online can help doctors schedule follow-up visits only when needed. About 250 adults with chronic skin conditions like eczema or psoriasis will either get standard fixed appointments or flexible scheduling based on m…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Spine fracture study to reveal hidden degeneration risks
Knowledge-focused Not yet recruitingThis observational study will follow 150 people with thoracolumbar spine fractures to see how the injury and its treatment (surgery or non-surgical care) affect joint and disc degeneration over time. Researchers will compare CT scans and pain scores between treated patients and a…
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Timing of gum disease check-ups could change treatment success
Knowledge-focused Not yet recruitingThis study looks at whether checking gum health 4 weeks after non-surgical treatment is better than waiting 8-10 weeks. Researchers will compare healing and pocket depth in 24 adults with advanced gum disease. The goal is to find the best time for follow-up to improve care.
Phase: NA • Sponsor: Gulf Medical University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Chewing gum test reveals hidden impact of gum disease
Knowledge-focused Not yet recruitingThis study will measure how well people with gum disease can chew. One hundred adults with periodontitis will chew a special gum for 20 cycles to test their chewing performance. Researchers will also check the severity of their gum disease to see if there is a link. This is an ob…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tiny study asks: can spine specialists see the same thing on CT?
Knowledge-focused Not yet recruitingThis study checks how consistently six doctors can grade degeneration of the small joints in the spine (facet joints) using CT scans. It includes 12 patients and uses the Pathria scale. The goal is to see if the grading method is reliable, not to test a treatment.
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New study uses DNA to track hidden gonorrhea in partners
Knowledge-focused Not yet recruitingThis study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple heart catheter test predict serious complications after myocarditis?
Knowledge-focused Not yet recruitingThis study investigates whether measuring blood flow in the heart's smallest blood vessels (microcirculation) can help predict serious health events within a year after a person is hospitalized for acute myocarditis. Researchers will use a special technique during a standard hear…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Will a new drug form work the same? study tests two versions of SKI-O-703
Knowledge-focused Not yet recruitingThis study tests whether two different capsule forms of the experimental drug SKI-O-703 are absorbed similarly in the body. About 48 healthy adults (Korean and Caucasian) will take a single dose of each form on separate days, with blood samples taken to compare drug levels. The r…
Phase: PHASE1 • Sponsor: Oscotec Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Home devices may spot lung flare-ups before they become emergencies
Knowledge-focused Not yet recruitingThis study tests whether people with fibrotic interstitial lung disease can use home monitoring devices—like a spirometer, pulse oximeter, and scale—to help detect serious lung events such as flare-ups or hospitalizations. About 200 participants will use these devices connected t…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Smartwatches may spot IBD flares before symptoms start
Knowledge-focused Not yet recruitingThis study explores whether changes in heart rate, sleep, and activity measured by a person's own smartwatch can predict flare-ups in inflammatory bowel disease (IBD). Six hundred adults with Crohn's disease or ulcerative colitis who already own a compatible device will participa…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists launch study to decode why diabetes affects people differently
Knowledge-focused Not yet recruitingThe EXPAND study is a research project that will enroll 440 adults with and without pancreatic conditions to understand why type 2 diabetes varies so much from person to person. Researchers will collect data on metabolism, genetics, and pancreas health to identify distinct diabet…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Blood test may spare ER patients from unneeded scans for clots
Knowledge-focused Not yet recruitingSuperficial vein thrombosis (SVT) is a painful but usually harmless blood clot just under the skin. However, about 4% of people develop more serious clots in deep veins or lungs. Current guidelines recommend ultrasound scans to decide if blood thinners are needed, but scans are o…
Sponsor: Dr. Kerstin de Wit • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Knee implant materials put to the test in human cells
Knowledge-focused Not yet recruitingThis study will test whether common orthopedic materials, like titanium alloy and polylactic acid (PLA), are safe for use in knee surgery. Researchers will expose human tissue samples from 50 knee replacement patients to these materials in the lab. They will check for cell damage…
Sponsor: Stefano Zaffagnini • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Blood test may predict PRP success for arthritic knees
Knowledge-focused Not yet recruitingThis study looks at whether a routine blood test can predict which patients with knee osteoarthritis will get good pain relief from platelet-rich plasma (PRP) injections. Researchers will enroll 120 people aged 40-60 with moderate knee arthritis. Each person will receive three PR…
Sponsor: Utku Gürhan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can a Year-Long training program make IVs safer for patients?
Knowledge-focused Not yet recruitingThis observational study will test a behavioral program designed to improve how nurses and anesthesiologists handle IV catheters. Over three years, one hospital will use the program while another continues usual care. Researchers will track complications like phlebitis and infilt…
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
800-Patient study aims to unlock secrets of autoimmune liver disease
Knowledge-focused Not yet recruitingThis French study will collect medical data and biological samples from 800 people with autoimmune liver diseases. Researchers hope to identify new markers that explain why some patients respond well to treatment while others do not. The goal is to better understand the immune me…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Knee pain relief starts in the mind: new study tests a health aid to bust common myths about osteoarthritis.
Knowledge-focused Not yet recruitingThis study will test whether a short health aid—a tool that corrects common misunderstandings about knee osteoarthritis—can help patients feel less worried and make clearer treatment choices. About 159 adults with knee osteoarthritis will be randomly assigned to review the health…
Phase: NA • Sponsor: David Ring • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can AI predict heart trouble in IBD patients?
Knowledge-focused Not yet recruitingThis study looks at people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, to better understand their risk of serious heart problems like stroke and heart attack. Researchers will collect information on therapy, disease activity, lifestyle…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study examines which IBD drugs are safer for seniors
Knowledge-focused Not yet recruitingThis study looked at nearly 24,000 older adults (65+) with ulcerative colitis or Crohn's disease to see if certain advanced treatments lead to more infections. Researchers compared patients taking ENTYVIO, TNF-alpha inhibitors, or ustekinumab using Medicare claims data from 2016 …
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test may reveal if allergy treatment is effective
Knowledge-focused Not yet recruitingThis study aims to develop a blood test that measures B regulatory cells, which may indicate whether allergen immunotherapy (allergy shots) is successfully reducing allergic reactions. Researchers will study 80 adults with pollen or venom allergies who are starting routine allerg…
Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Greek sinusitis study aims to personalize treatment by analyzing inflammation
Knowledge-focused Not yet recruitingThis study will collect and analyze nasal tissue from 230 Greek patients with chronic sinusitis (with or without nasal polyps) to identify different inflammation patterns, called endotypes. By understanding these patterns, researchers hope to better match patients with the most e…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Rare bone infection study aims to uncover best treatment paths
Knowledge-focused Not yet recruitingThis study follows 100 adults diagnosed with skull base osteomyelitis, a rare and serious bone infection near the ear and skull base. Researchers will track how often the infection returns or leads to death within 12 months. The goal is to gather real-world data to help standardi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists watch thumb muscles in action to improve osteoarthritis rehab
Knowledge-focused Not yet recruitingThis study looks at how two thumb muscles work in people with and without thumb base osteoarthritis while they do six daily tasks like turning a key or writing. Researchers will use sticky sensors to record muscle activity. The goal is to find differences that could lead to bette…
Sponsor: University of Malaga • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain scans reveal why some knee pain feels different
Knowledge-focused Not yet recruitingThis study uses brain MRI to compare brain activity in women over 40 with knee osteoarthritis who have two different types of pain: joint-related pain and nerve-related pain. Researchers will look at a brain region called the anterior insula to see if activity differs between the…
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could skipping bowel prep before colon surgery be just as safe?
Knowledge-focused Not yet recruitingThis study looks at whether it's safe to skip mechanical bowel preparation (the drink that cleans out your colon) before colon surgery. Currently, the best practice combines that drink with antibiotics to prevent infections. The trial will compare two groups: one getting the drin…
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to understand physical challenges in kids with nerve diseases
Knowledge-focused Not yet recruitingThis study will look at balance, core strength, leg strength, walking ability, and fatigue in 32 children aged 6-18 with demyelinating diseases (conditions affecting the protective coating of nerves). Each child will undergo a single session of non-invasive tests like balance exe…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Egyptian HAE patients to be studied for better care insights
Knowledge-focused Not yet recruitingThis study will collect information from medical records and routine clinic visits of 100 people in Egypt with hereditary angioedema (HAE) type I or II. The goal is to understand how the condition is diagnosed and managed in current medical practice. No new treatments are being t…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Music may soothe chemo mouth sores in kids
Knowledge-focused Not yet recruitingThis study looks at whether music therapy can reduce painful mouth sores (oral mucositis) in children with cancer. Researchers will interview 50 families online to learn about their experiences with music therapy. The goal is to find patterns that could lead to better, drug-free …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study to measure drug levels in breast milk of moms on TREMFYA
Knowledge-focused Not yet recruitingThis study will measure how much of the drug TREMFYA (guselkumab) passes into breast milk of 10 nursing women who are already taking it for conditions like psoriasis, psoriatic arthritis, ulcerative colitis, or Crohn's disease. Researchers will collect milk samples to estimate th…
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New blood test may predict infection risk after liver transplant
Knowledge-focused Not yet recruitingThis study aims to create a score that predicts the risk of infection within 30 days after a liver transplant. Researchers will collect blood samples from 279 liver transplant patients before and after surgery to measure immune markers. The goal is to combine these markers with o…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could we ditch antibiotics after a burst appendix? new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at whether it is safe to stop giving antibiotics after surgery for a burst (perforated) appendix. About 100 adults will be randomly assigned to receive either antibiotics or no antibiotics after their operation. The main goal is to see if a larger study is …
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Personalized videos may make colonoscopy prep easier for IBD patients
Knowledge-focused Not yet recruitingThis study tests whether watching a short video tailored to their specific type of inflammatory bowel disease (IBD) helps patients better prepare their bowel for a colonoscopy. About 600 adults with ulcerative colitis or Crohn's disease will be randomly assigned to receive either…
Phase: NA • Sponsor: Jie Liang • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tired athletes at risk? new study uses smartphones to analyze landings
Knowledge-focused Not yet recruitingThis study looks at how muscle tiredness changes the way female volleyball players move their legs when landing on one foot. Researchers will use smartphone videos to measure hip, knee, and ankle motion in 35 athletes. The goal is to understand injury risks better, not to test a …
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood fats and nanoparticles may reveal hidden clues in autoimmune liver disease
Knowledge-focused Not yet recruitingThis study looks at two types of liver disease — autoimmune hepatitis and non-alcoholic fatty liver disease — to see if fats in blood cells and tiny particles called extracellular vesicles differ between them. Researchers will collect blood samples from 24 adults and analyze thes…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Robot-Assisted joint surgery under the microscope: will it help implants last longer?
Knowledge-focused Not yet recruitingThis study will follow about 950 people who receive hip or knee replacements using Stryker implants, some with the Mako robotic-arm system and some without. Researchers will track how long the implants last and how well patients feel and function over five years. The goal is to g…
Sponsor: Stryker Orthopaedics • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to take the guesswork out of emergency diverticulitis surgery
Knowledge-focused Not yet recruitingThis observational study will collect detailed information from 150 adults undergoing emergency surgery for complicated diverticulitis. Researchers will analyze factors that influence surgeons' decisions to perform either a primary anastomosis (reconnecting the bowel) or a Hartma…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists investigate mysterious loin pain in kidney disease
Knowledge-focused Not yet recruitingThis study looks at what changes occur in the kidneys, urine, and blood when people with IgA nephropathy (IgAN) experience loin pain. Researchers will use MRI scans and lab tests to compare findings during a pain episode and when pain-free. The goal is to better understand the ca…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Emotional blindness may sabotage knee pain therapy
Knowledge-focused Not yet recruitingThis study investigates whether alexithymia—a condition where people struggle to identify and describe their emotions—affects how well patients with knee osteoarthritis respond to physical therapy. Sixty participants aged 40 to 75 with moderate knee osteoarthritis will receive a …
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New scan could reveal hidden immune cells in blood vessel disease
Knowledge-focused Not yet recruitingThis study will use a special scan to look for B cells (a type of immune cell) in the blood vessels of 30 people with giant cell arteritis, a serious disease that can cause blindness or stroke. Current treatments rely on steroids, which have harsh side effects. If the scan works,…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood marker may reveal hidden inflammation in arthritis patients
Knowledge-focused Not yet recruitingThis study will measure a protein called IL-41 in the blood of 90 people with ankylosing spondylitis or psoriatic arthritis, plus healthy volunteers. Researchers want to see if higher levels of this protein are linked to more active disease. The goal is to find a simple blood tes…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gum treatment may improve chewing, study hopes to prove
Knowledge-focused Not yet recruitingThis study looks at whether treating gum disease (periodontitis) can improve how well people chew and their overall oral quality of life. Researchers will ask 44 adults with gum disease to fill out questionnaires, do a chewing test with colored gum, and provide saliva samples. Th…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple score predict pancreatitis death in seniors?
Knowledge-focused Not yet recruitingThis study looks at two scoring systems, NEWS-2 and NEWS-Calcium, to see which better predicts the risk of dying in the hospital for people aged 65 and older with acute pancreatitis. Researchers will review medical records of 350 patients to compare the scores. The goal is to hel…
Sponsor: Antalya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New study tests if injecting drug into bone works better than IV during joint replacement
Knowledge-focused Not yet recruitingThis study looks at 80 people having hip or knee replacement surgery to compare two ways of giving a drug called tranexamic acid, which helps reduce bleeding. Half will get the drug through a standard IV, and the other half will get it injected into the bone. Researchers will mea…
Phase: PHASE4 • Sponsor: Hua Luo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Hidden nerve damage may worsen life for ankylosing spondylitis patients
Knowledge-focused Not yet recruitingThis study will check 45 adults with ankylosing spondylitis for peripheral neuropathy (nerve damage in the arms and legs) using nerve conduction tests. Researchers want to see if nerve problems are linked to higher disease activity, increased pain sensitivity, and worse quality o…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Skin deep: european study probes the hidden emotional toll of skin diseases
Knowledge-focused Not yet recruitingThis study looks at how people with skin conditions (like eczema, psoriasis, or skin cancer) manage stress, feel lonely, and bounce back from challenges. Researchers will compare 375 adults with and without skin disease across 15 European countries using questionnaires. The goal …
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New MRI methods could spot liver damage earlier
Knowledge-focused Not yet recruitingThis study tests new MRI techniques to measure blood flow and tissue details in the liver. Researchers will scan 110 people, including healthy volunteers and those with chronic liver disease or fibrosis, to see if these scans can reliably detect liver damage. The goal is to devel…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Blood test could predict vasculitis relapse, study hopes
Knowledge-focused Not yet recruitingThis study follows 120 adults with ANCA-associated vasculitis, an autoimmune disease, who are receiving rituximab therapy. Researchers will collect blood samples over time to look for immune cell changes that signal a coming relapse. The goal is to find biomarkers that help docto…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Parents as ear infection detectives: new study tests home otoscopy
Knowledge-focused Not yet recruitingThis pilot study will test if parents can learn to use a digital otoscope (ear camera) at home to check for ear infections in their young children. About 40 children aged 1-4 who have had ear infections before will take part. Parents in the study group will get training and a dev…
Phase: NA • Sponsor: Turku University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists hunt for hidden ARDS subtypes to crack deadly lung failure
Knowledge-focused Not yet recruitingThis study will analyze samples from 130 ICU patients with ARDS (a severe lung injury) to better understand why the condition varies so much between people. Researchers will examine lung fluid, blood, and CT scans to identify distinct biological subtypes. The goal is not to test …
Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Which PRP machine works best for knee arthritis? small study aims to find out
Knowledge-focused Not yet recruitingThis study will compare two FDA-approved machines that make platelet-rich plasma (PRP) for people with knee osteoarthritis. PRP is made from a person's own blood and is injected into the knee to help with pain and stiffness. The researchers will check if the two machines produce …
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Grinding teeth? your mental health may be hurting your gums
Knowledge-focused Not yet recruitingThis study looks at how mental health, especially stress, affects gum disease in people who grind their teeth. About 110 adults aged 30-50 with both teeth grinding and gum disease will answer mental health questions and get a dental check-up. The goal is to see if poor mental hea…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could cutting salt soothe your skin? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether changing how much salt you eat can affect skin sodium levels and the severity of eczema or psoriasis. Fifty adults will follow a low-salt diet and take either sodium tablets or a placebo for several weeks. The goal is to see if this approach is practic…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can a single chat with a partner keep people who inject drugs in care?
Knowledge-focused Not yet recruitingThis pilot study tests a one-time 'booster' session for people who inject drugs and their injecting partners, given right after finishing hepatitis C treatment. The session helps them set health goals, identify barriers, and improve communication to stay engaged in ongoing health…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Scientists hunt for protein clues in severe dry eye treatment
Knowledge-focused Not yet recruitingThis study aims to understand why some patients with severe dry eye syndrome improve with autologous serum eye drops while others do not. Researchers will analyze the protein makeup of the drops from 68 participants over 6 months. The goal is to identify which proteins are linked…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden muscle loss in young arthritis patients under the microscope
Knowledge-focused Not yet recruitingThis study looks at how often muscle weakness and loss (sarcopenia) happens in people aged 15 to 40 with juvenile idiopathic arthritis. Researchers will measure grip strength, do body scans, and use questionnaires to check muscle health. The goal is to find out how common this pr…
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
France launches massive virus surveillance in GP clinics
Knowledge-focused Not yet recruitingThis study will track which respiratory viruses—like flu, COVID-19, and RSV—are circulating in French primary care clinics each winter. Up to 25,000 patients with cold or flu symptoms will provide a saliva or nose swab sample. The goal is to monitor virus activity and help guide …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Oxygen flow study aims to boost safety during bladder scope sedation
Knowledge-focused Not yet recruitingThis study looks at how different rates of high-flow oxygen affect oxygen levels in the blood and brain during sedation for a bladder scope procedure (cystoscopy). About 200 adults will be randomly assigned to receive one of three oxygen flow rates while their breathing and oxyge…
Phase: NA • Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Root canal Patients' bite strength tracked for 4 years
Knowledge-focused Not yet recruitingThis study follows 70 adults aged 20-60 who need root canal treatment on a premolar or molar. Researchers measure how hard they can bite and how force spreads across teeth before treatment, after root canal, after a crown, and up to 4 years later. They also ask about chewing comf…
Sponsor: Chulalongkorn University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Grinding your teeth? stress and poor sleep may worsen gum disease
Knowledge-focused Not yet recruitingThis study looks at how stress levels, sleep quality, and teeth grinding (bruxism) together affect gum disease in adults aged 30-45. Researchers will compare two groups of people with gum disease: those who grind their teeth and those who do not. The goal is to understand how the…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can a team approach to bubble CPAP help kids with pneumonia? a feasibility trial begins
Knowledge-focused Not yet recruitingThis study tests whether a team-based care strategy for bubble continuous positive airway pressure (bCPAP) is feasible for children with severe pneumonia in Pakistan. Researchers will enroll 95 children and their caregivers to see if a larger trial is possible. The focus is on wh…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Gritty mind, healthier gums? new study to test if resilience shields teeth grinders from Stress-Related gum disease
Knowledge-focused Not yet recruitingThis study looks at whether psychological resilience — the ability to bounce back from stress — can reduce the harmful effects of stress on gums in people who grind their teeth (bruxers). Researchers will measure stress and resilience using questionnaires and check gum health in …
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Grain-of-Rice device could end guesswork in skin treatment
Knowledge-focused Not yet recruitingThis study tests a tiny microdevice, about the size of a grain of rice, that holds up to 20 different FDA-approved skin medications. Placed directly on the skin, it releases very small amounts of each drug to see how the skin reacts. The goal is to find out if this device can saf…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a quick quiz replace gym tests for kids with chronic illness?
Knowledge-focused Not yet recruitingThis study checks whether two short questionnaires can accurately measure physical fitness in children aged 10–18 with juvenile idiopathic arthritis or familial Mediterranean fever. Researchers will compare the questionnaire results with standard fitness tests. If the questionnai…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to reduce dangerous clots after complex pancreatic surgery
Knowledge-focused Not yet recruitingThis study looks at why some patients develop blood clots after pancreatic surgery that also involves removing a piece of a major vein. Researchers will collect information from over 1,000 patients across many hospitals to see how surgical techniques and blood-thinning medication…
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Gum disease study aims to put a number on dental health value
Knowledge-focused Not yet recruitingThis study looks at how people with gum disease (periodontitis) value their dental health and how their oral health beliefs relate to the severity of their condition. Researchers will ask 112 adults aged 30-50 to complete questionnaires and a clinical exam in one visit. The goal …
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
3D models reveal best thumb surgery for arthritis pain
Knowledge-focused Not yet recruitingThis study looks at how thumb arthritis changes joint pressure and how two types of surgery (with or without a metal implant) affect that pressure. Researchers will use CT scans and computer models to simulate loads in the thumb joint. 40 adults aged 50 to 88 with moderate to sev…
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New eye imaging study aims to map retinal disease progression
Knowledge-focused Not yet recruitingThis observational study will use advanced imaging techniques to measure changes in the retina and choroid (the layer beneath the retina) in people with eye diseases and healthy volunteers. Over 5 years, researchers will track thickness and blood vessel density to better understa…
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
AI to predict cancer risk from gut bacteria and scans
Knowledge-focused Not yet recruitingThis study will collect data from 10,000 people undergoing upper endoscopy to build an AI model that predicts the risk of developing stomach or esophageal cancer. Researchers will combine information from endoscopy images, tissue samples, genetics, and gut bacteria. Participants …
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Heart hope for HS patients: drug may slow artery plaque
Knowledge-focused Not yet recruitingThis study follows 34 adults with moderate-to-severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their routine care. Researchers will use a special CT scan to check if the drug affects the buildup of plaque in the heart arteries over 12 months. The goal is…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Can immune clues predict pancreatic cancer in pancreatitis patients?
Knowledge-focused Not yet recruitingThis study will follow 800 people, including those with chronic pancreatitis, pancreatic cancer, and healthy volunteers, to learn why some pancreatitis patients later get pancreatic cancer. Participants give blood samples and health info; some may also provide tissue samples. Res…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Scientists probe epigenetic link between obesity and gum inflammation
Knowledge-focused Not yet recruitingThis study looks at how obesity changes the way genes work in people with gum disease. Researchers will compare obese and non-obese adults before and after a deep cleaning treatment. They aim to understand why obese individuals may have worse gum inflammation and how it might be …
Phase: NA • Sponsor: Louisiana State University Health Sciences Center in New Orleans • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Gum study could unlock secrets of Body's immune response
Knowledge-focused Not yet recruitingThis study looks at how gum inflammation and the bacteria in your mouth interact with your body's immune system. Twenty healthy adults will use a special toothpaste and then stop brushing for a period to see how inflammation and bacteria change. The goal is to better understand t…
Phase: PHASE4 • Sponsor: Colgate Palmolive • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Spit test may spot reflux risk after gastric sleeve surgery
Knowledge-focused Not yet recruitingThis study looks at whether measuring bile acids and pepsin in saliva can help identify people who develop acid reflux or esophageal damage after sleeve gastrectomy (a type of weight-loss surgery). About 60 adults will give saliva samples before surgery and again 1 and 3 years af…
Sponsor: Hospital de Mataró • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Toe fusion study: can you ski after surgery?
Knowledge-focused Not yet recruitingThis study follows 150 people aged 18-60 who had big toe fusion surgery for hallux rigidus or hallux valgus. Researchers want to see how well patients return to physical activities, especially cross-country skiing, by comparing current sports function to before surgery. Participa…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New registry tool aims to stop heart patients from falling through the cracks
Knowledge-focused Not yet recruitingThis study tests a cloud-based tool called ACT+ to help people in Uganda get follow-up care after a positive screening for rheumatic heart disease. Researchers will work with local providers to improve the tool and then see if it increases the number of people who complete a conf…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Could menopause and blood sugar be tied to frozen shoulder? new study aims to find out
Knowledge-focused Not yet recruitingThis study will explore if menopause and blood sugar levels are linked to frozen shoulder in women. Researchers will survey women who have had frozen shoulder and closely monitor a smaller group of perimenopausal women with and without the condition. The goal is to understand why…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
500 patients to help unlock secrets of knee recovery
Knowledge-focused Not yet recruitingThis study will follow 500 people with knee injuries or knee osteoarthritis who receive standard care at a hospital in China. Researchers will collect medical history, imaging, and function tests at the start and then again at 6, 12, and 24 months. The goal is to better understan…
Sponsor: Ningbo No.2 Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New study tracks how a Gut-Joint drug works in real time
Knowledge-focused Not yet recruitingThis study follows 75 adults with Crohn's disease or ulcerative colitis who are starting guselkumab, a drug used for inflammatory bowel disease. Researchers want to see if the drug also helps with joint pain and stiffness linked to spondyloarthritis. Participants will report symp…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Gum disease link in mouth condition under investigation
Knowledge-focused Not yet recruitingThis study looks at whether people with oral lichen planus (a chronic mouth condition) have more gum disease than those without it. Researchers will compare 88 patients with oral lichen planus to 88 healthy people, all getting standard dental exams. The goal is to understand shar…
Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Your phone could predict arthritis before it strikes
Knowledge-focused Not yet recruitingThis study tests whether smartphone data and optional smartwatches can detect early signs of psoriatic arthritis in people with psoriasis. About 3,458 adults with psoriasis but no arthritis will use an app that passively collects phone data. The goal is to develop algorithms that…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Could lynch syndrome raise your risk of gum disease?
Knowledge-focused Not yet recruitingThis study will check if people with Lynch syndrome, a genetic condition that raises cancer risk, have more gum disease than the general population. Researchers will look at dental records from 25 adults with Lynch syndrome. The goal is to see if gum disease is a hidden health is…
Sponsor: Rotundo Roberto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Scientists probe cellular 'Power Plants' to unlock secrets of aging
Knowledge-focused Not yet recruitingThis study looks at how aging changes tiny parts of our cells called mitochondria, which produce energy. Researchers will take small skin samples and blood from 90 healthy adults aged 18-90 to measure inflammation and cell aging markers. The goal is to better understand why we ag…
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New rehab pathway aims to close recovery gaps after knee surgery
Knowledge-focused Not yet recruitingThis study will test a new care pathway for rehabilitation after total knee replacement. The pathway includes a patient education booklet and optimized scheduling of physical therapy. Researchers want to see if this approach improves recovery and reduces differences based on race…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Gum disease study looks at healing markers in pocket fluid
Knowledge-focused Not yet recruitingThis study will measure certain proteins and antioxidants in the fluid from gum pockets in 21 adults with gum disease. Researchers will take samples before and after a deep cleaning procedure (scaling and root planing) to see how these markers change during healing over 3 months.…
Phase: NA • Sponsor: Zeyad Nazar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
French study maps hepatitis c subtypes to improve treatment
Knowledge-focused Not yet recruitingThis study looks at 2,500 people newly diagnosed with hepatitis C in France. Researchers will use existing medical data to map the different virus types and subtypes, including rare ones. The goal is to understand which types are most common and why some treatments fail, helping …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Gum treatment may unlock heart health secrets
Knowledge-focused Not yet recruitingThis study looks at whether a deep dental cleaning (called non-surgical periodontal therapy) can change levels of a substance called asprosin in the blood of people who have both stable angina and gum disease. Asprosin is a protein that may play a role in heart health and inflamm…
Phase: NA • Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Night shift Workers' gums under the microscope: body clock linked to inflammation
Knowledge-focused Not yet recruitingThis study looks at how a disrupted body clock (like in night-shift workers) affects gum inflammation. Researchers will measure clock proteins and immune markers in the gum fluid of 116 people with and without gum disease. The goal is to understand the link between sleep-wake cyc…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New wrist gadget aims to cut down on repeat X-Rays
Knowledge-focused Not yet recruitingThis study will test a new positioning aid called Tru-Vu that helps radiographers take clearer wrist x-rays. About 1,800 adults with wrist injuries or arthritis will be included across three different healthcare centers in Newfoundland and Labrador. Researchers want to see if the…
Phase: PHASE3 • Sponsor: Western University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Leg vein problems may slow recovery after knee surgery
Knowledge-focused Not yet recruitingThis study will follow 100 people getting a total knee replacement to see if those with chronic venous insufficiency (poor blood flow in leg veins) have more wound healing problems. Participants will have an ultrasound before surgery to check their veins and then be monitored for…
Sponsor: SB Istanbul Education and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC